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Abstract
The transition from traditional batch blending to continuous blending is an opportunity for the
pharmaceutical industry to reduce costs and improve quality control. This operational shift
necessitates a deeper understanding of the mixing process informed by particle dynamics and
variable interdependencies. The thesis aims to establish a framework for characterizing and
improving continuous pharmaceutical blending using a tiered experimental methodology and
multivariate analysis. This parameter space exploration attempts to reconcile previous research
within the context of cohesive pharmaceutical powders and develop general design principles for
maximizing blender performance.
A design of experiments was conducted to determine mixing performance with respect to three
factors - physical design, operating parameters, and material properties. Multivariate analysis
using projections to latent structures was employed to quantify the effect of raw and intermediate
variables on the variance reduction ratio. Significant parameters identified included the choice of
API, fill fraction, the number of blade passes, the mean residence time, the Bodenstein number,
and the period of input feed fluctuations. The results highlight the importance of shear and radial
mixing for cohesive powders, which suggest that one-dimensional axial models common in
blending literature may not be a sufficient theoretical framework for pharmaceutical applications.
The research yielded several insights into design principles for optimizing blending performance.
Increasing mean residence time and radial mixing create more robust processing by reducing the
impact of material properties and fluctuations in feed consistency. The variance reduction ratio
can be improved in a cost-effective manner by determining the fill fraction which maximizes
intermediate metrics such as space time, mean residence time, and the number of blade passes.
Multivariate analysis was demonstrated to be a practical tool for parameter space optimization
and a promising technique for characterizing the effect of material properties on processing.
Thesis Supervisor: Charles L. Cooney
Title: Robert T. Haslam (1911) Professor of Chemical Engineering
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1 Introduction
Pharmaceutical manufacturing has not changed drastically over the last century. In an industry
fueled by waves of newer and better products, discovering the next blockbuster drug has always
taken precedence over process innovation. Pharmaceutical innovation was focused on developing
novel compounds and driving sales growth, rather than optimizing operations and reducing costs.
In the years of high profit margins and seemingly limitless product opportunities, this was not a
problem. More recently, cost pressures have mounted as traditional pharmaceutical giants face
competition from both smaller biotechnology companies and generic manufacturers.
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Figure 1-1: Branded Drugs Facing the Patent Cliff
In the next few years, patent protection on a host of blockbuster drugs is expected to expire,
costing pharmaceutical companies billions of dollars in annual recurring revenue. The impending
patent cliff will erode a stable base of sales for the industry, weakening growth prospects in the
near-term. Figure 1-1 shows the anticipated losses over the coming decade, according to a
Thomson Reuters report [1]. Pharmaceutical giants will lose patent protection on over 200
branded products that generated over $100B in combined global sales in 2010. Chief among
these expiring blockbusters are Lipitor, Advair, and Seroquel, three of the top five prescription
drugs by revenue. Given this stark industry outlook, pharmaceutical companies may renew their
focus on costs and operations. In this current climate, increased attention towards streamlining
drug development and manufacturing may be a way to do more with less capital.
1.1 What Is Pharmaceutical Blending?
In traditional pharmaceutical manufacturing, the active pharmaceutical ingredient is embedded
as a compressed dry powder in the final product, most commonly a tablet or capsule. This process
can be split into two tasks - the API is chemically synthesized, then formulated with excipients
to create the final drug product. The latter, often called secondary or downstream pharmaceutical
manufacturing, involves a series of processing operations to convert the API into end user form.
Figure 1-2 shows a typical sequence of pharmaceutical manufacturing processes. Common steps
include crystallization, drying, granulation, blending, tabletting, coating, and packaging. Each
unit operation is carefully calibrated such that the drug product conveys the appropriate usability
and pharmacokinetic profile.
Upstream Downstream
Reaction Crystallization Granulation Drying
Figure 1-2: Process Schematic of Pharmaceutical Manufacturing
Blending is a pivotal step in maintaining the quality of secondary pharmaceutical manufacturing.
During this process, the API is mixed with a pre-specified formulation of excipients designed to
influence bulk density, dissolution properties, and flowability. After mixing, the drug product is
locked in its final dosage form. Blending is then the last opportunity for product variance to be
managed and minimized. Homogeneity is critical to drug quality as the local composition of
materials in the formulation dictates its processing properties and pharmacokinetic profile. Most
importantly, blending is responsible for controlling the accurate dosage of the API across the
millions of tablets in each manufacturing run. As drugs become more potent and targeted, a
robust blending operation becomes ever more critical to a safe and reliable drug production
system [2]. Mixing is thus a key process to understand and streamline in any effort to improve
pharmaceutical operations and reduce costs.
1.2 What Is Continuous Manufacturing?
Like other pharmaceutical processing steps, the majority of blending is currently conducted in
batch mode. In batch operations, each step of the manufacturing process is run to completion as
defined by a pre-specified performance metric. Material is then transported to the next step in a
sequential and step-wise manner. Batch operations provide a number of advantages, primarily in
reducing system complexity. Material can be tracked in distinct lots and batches since product is
housed in distinct equipment units throughout the manufacturing process. This separation of
equipment and material eases regulatory compliance and provides a natural buffer time between
steps to check quality.
Recently, the pharmaceutical industry and the US Food and Drug Administration have pushed
towards a continuous manufacturing paradigm [3]. The Consortium for the Advancement of
Manufacturing of Pharmaceuticals has defined continuous manufacturing as the "processing of
raw materials without interruption and with continuity of production over a sustained period of
time". Continuous processing confers several advantages discussed below.
Steady-State Operation at Lower Scale
Continuous manufacturing is designed to run effectively at steady-state with little downtime.
Using proper monitoring and control, operations can be performed on an extended schedule with
minimal supervision. This allows a continuous process with a constant throughput to scale-up
simply through longer run times. This scalability provides greater operational flexibility during
drug development and clinical trials and also enables the target production rate to be achieved
with smaller equipment. Continuous processing also eliminates accumulation of material during
manufacturing, thus reducing work in process and material containment issues.
Reduced Capital Requirements
A corresponding advantage to the lower scale of operation is reduced capital requirements. The
smaller sizing of equipment also reduces space and support requirements, allowing a plant to be
constructed at a lower capital cost. The decrease in cycle time and work in process also yields
lower working capital. Continuous processing promotes a lean manufacturing methodology
which increases process efficiency and return on capital.
1.3 Current Challenges
At its heart, continuous pharmaceutical manufacturing can be viewed as an attempt to treat the
processing of dry pharmaceutical powder in the same way as the processing of fluids. By moving
material automatically and uniformly from step to step, queuing and transfer issues no longer
arise. However, the imposition of movement along an organized production line necessitates a
much deeper understanding of the process timing. In batch blending, a run which did not meet
homogeneity standards could simply be repeated at the cost of a time delay. In continuous
blending, the unmixed material would proceed through the manufacturing process, resulting in
unusable product and wasted operating time. The greater consequences of a failed run mean that
operations must be rigorously optimized for both robustness and performance.
Understanding of particle systems has been historically sparse compared to research into fluid
systems. Bridgwater noted that while 60% of the products of the chemical industry are in solid
form, chemical engineering undergraduate curriculums contain little on particle technology [4].
This discrepancy has been exacerbated by difficulties in characterization of solids processing.
Prior to the advent of optical imaging methods, offline sampling of material was the industry
standard for evaluating pharmaceutical blending. Recent analytical methods such as positron
emission particle tracking, light-induced fluorescence, and near-infrared spectroscopy have been
powerful improvements in peering into solids dynamics.
The opportunity then is to apply new frameworks for understanding and characterizing particle
systems to solve the current challenges in pharmaceutical manufacturing. Research on continuous
processing from the food and chemicals industries can be combined with new optical imaging
methods to provide insight and elucidate design principles for continuous manufacturing in the
dry powder context. These findings can then be used to improve the current inefficiencies in
pharmaceutical manufacturing.
1.4 Thesis Outline
The thesis begins with an abbreviated literature review in Chapter 2 highlighting specific insight
which informed the development of this work. Given the current state of blending research,
Chapter 3 lays out the thesis objectives. Next, Chapter 4 presents theoretical simulations
conducted to establish a baseline understanding of blending dynamics. Chapter 5 describes the
experimental methodology, including overall design rationale, types of experiments, and
analytical techniques employed. The results are presented and discussed in the next 3 chapters.
Chapter 6 focuses on findings from the double helical ribbon blenders, from fill weight data to
residence time distribution data and variance reduction ratios. The same layout is repeated in
Chapter 7 for the paddle blender. The whole data set is then aggregated for multivariate analysis
in Chapter 8, followed by a discussion of the implications for future blender design and potential
avenues for further work. The multivariate analysis is applied to an evaluation of pharmaceutical
revenue growth with respect to research and development spending in Chapter 9, followed by
conclusions in Chapter 10.
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2 Literature Review
The research on powder blending has focused on developing a fundamental understanding of the
mixing process to elucidate further improvements and enhance predictive power. Within this
body of work, several reviews cover the theory and practice of powder blending over time. Fan et
al. [5, 6] documented theoretical work to define mixing performance and surveyed the
development of mixing mechanisms and models for specific blenders. Williams [7] detailed
relevant applications to continuous drum mixers. Poux et al. [8] provided a review of practical
distinctions between different mixing systems. Pernenkil and Cooney [9] summarized the state
of work with a comprehensive list of modeling methodologies and monitoring techniques.
This review serves as a supplement to existing surveys, particularly the work of my predecessor
Lakshman Pernenkil. Specific emphasis is placed on recent developments where technological
advancements have yielded new contributions to conventional understanding of powder
blending. The review is divided into three portions - 1) practical theoretical applications to
continuous mixing, 2) the mechanics of mixing, and 3) recent experimental findings.
2.1 Models of Continuous Mixing
Two theoretical frameworks for continuous mixing are highlighted here - the axial dispersion
equation and Markov chain theory. Due to current computational limitations in expanding up to
experimental scale, discrete element method simulations are considered impractical for cohesive
applications and not covered. Specifics of research implementation are discussed in detail in the
experimental methodology.
2.1.1 Axial Dispersion Equation
When blending is transformed into a continuous process, forward axial motion is superimposed
on top of convective and diffusive mixing in the radial and axial directions. This can be
accomplished by designing to agitator to impart forward momentum. If loading fraction is to
remain a variable parameter, the blender must have the capacity to carry powder at a faster rate
than the throughput. Since the mixer length is usually significantly larger than the diameter,
mixing in the radial direction is simply assumed, while greater efforts are spent on ensuring axial
homogeneity. Ghaderi [10] notes that particles that enter the system simultaneously should be
delayed by different amounts of time in order to smooth out input axial fluctuation patterns.
This concept of axial mixing can be characterized using the general transport equation of the
axial dispersion model [11-15]. As shown in Equation (2-1), both convective and diffusive terms
are incorporated into transient transport in the axial dimension. When non-dimensionalized into
Equation (2-2), the characteristic parameter is the Bodenstein number, the solid equivalent of the
Peclet number for fluid transport, which relates convective to diffusive motion. Hence, low
Bodenstein numbers indicate a high degree of axial mixing. When the equation is solved for
closed boundary conditions, the concentration at the outlet of the blender yields the residence
time distribution, plotted in Figure 2-1 for a wide range of Bodenstein numbers and normalized
space times. The RTD can vary from the plug flow model for no dispersion to the continuously
stirred tank model for infinitely high dispersion. In this one-dimensional model, the mean
residence time, the average velocity, and the axial dispersion are the only metrics necessary to
characterize blender dynamics.
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The most direct measure of blending performance in literature is the variance reduction ratio,
defined as the variance in the material of interest at the mixer inlet divided by the variance at the
outlet. Equation (2-3) shows the relationship between VRR and the Danckwerts model, which
postulates that the VRR can be calculated using the autocorrelation functions of the residence
time distribution and the input feed profile. Note that for solids mixing, another term is
appended to the Danckwerts model to account for the random mixture limit, an upper bound on
physically achievable performance in the blending of dry solids.
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Figure 2-1: Residence Time Distributions for Varying Axial Dispersions
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The homogeneity of the mixer output is thus dependent on both the blender performance and
the input consistency. It is difficult for the blender to smooth out feeding variations that occur
beyond the mean residence time - leading to the circuit analogy that blenders act like a low-pass
filter. This concept can be tested by feeding the blender in a sinusoidal pattern and varying the
oscillation frequency. For feed variations that are not perfectly sinusoidal, the same analysis can
be conducted in the frequency domain by performing a Fourier transform on the input and
output concentration profiles. The resulting power density spectrum can be used to calculate the
VRR at each frequency by dividing the input value by the output value. The VRR can also be
plotted against the period or the frequency of the feeding fluctuation to provide an indication of
how robust the blending process is. The theoretical work of Danckwerts and the experimental
data presented by Weinekotter and Reh [15] both suggest that the VRR can be improved by
increasing the axial mixing, increasing the mean residence time, or by decreasing the perturbation
frequency of the input feed. In the one-dimensional paradigm of continuous blending, these
variables are the key to maximizing fundamental performance within a given design space.
2.1.2 Markov Chain Theory
One-dimensional axial movement along a blender can also be modeled via Markov chain theory,
a theoretical construct wherein the system is sliced into discrete chambers and flow through the
system is characterized as a series of probabilities of movement. For any given system profile
represented by probabilities, inputs can be altered and outputs simulated in order to predict the
system response. The advantage of Markov chain theory is the linear algebra framework, which
makes the simulation analytically tractable in one- and two-dimensional models. As the unit of
interest here is a chamber rather than a discrete particle, Markov models are easier to scale up
compared to discrete element method simulations, which approach computational limitations in
the 109 particle range [16].
Marikh et al. [17] applied a Markov model to experimental powder mixing data and validated its
use in characterization of continuous mixing. The framework has also been extended to static
mixers [18] and hybridized with discrete element method [19]. The model provides an
alternative paradigm for characterizing a blending system, with greater flexibility to account for
complex designs such as asymmetry or irregular shaft elements. However, Markov chains can still
be reduced to the same number of independent parameters as the axial dispersion model with
appropriate assumptions for system uniformity and powder dynamics. A deeper explanation of
Markov chain theory is included in the theoretical work discussed in Chapter 4.
2.2 Mechanics of Mixing
Powder mixing is caused by relative differences in powder flow, leading to a rearrangement in
particle positions. Mixing can occur through two mechanisms - convection refers to blending
due to bulk movement of powder, while diffusion refers to random movement of powder across
slip planes or free surfaces. It is important to note that the smallest unit in solid mixing is the
particle, while the smallest unit in fluid mixing is the molecule. In this case, diffusion does not
occur due to Brownian motion, but only through the input of mechanical energy to displace
particles. In addition, agglomeration and deagglomeration can also have a significant impact on
output homogeneity. Shear forces are thus another important mechanism to consider, given the
impact of cohesion and adhesion of the interaction of pharmaceutical particles [20].
Powder flow can first be understood at simpler geometries, such as a rotating cylinder used in
horizontal drum mixers. Mellmann [21] examined transverse bed behavior in a partially filled
rotating cylinder and categorized the forms of motion based on rotation speed. At the slowest
speeds, the bed constantly slides from the wall, causing the tube to rotate while the bed appears
to rest at a slight angle of repose. As the rotation rate increases, the solid bed is elevated higher,
causing intermittent avalanching to produce a slumping behavior. This motion transitions into a
continuous flow of material down the free surface of the bed to yield a rolling action. At higher
speeds, powder is lifted even higher and the bed surface begins to arch as cascading sets in.
Eventually, more and more individual particles are flung up and out of the bed to produce the
cataracting and centrifuging motions.
Sherritt et al. [22] determined that different degrees of axial dispersion were associated with each
form of bed motion. Other significant parameters included rotation speed, degree of fill, drum
diameter and particle diameter. Other material properties can also greatly impact mixing
mechanics. Faqih et al. [23] explored the extent to which cohesive granular materials expand in
response to mechanical agitation. In simple cylinders, the powder bed may dilate 10-40%
depending on powder size and cohesion. The dilation effect during powder motion effectively
reduces the bulk density of the formulation during mixing.
The process geometry has a significant impact on powder flow, and consequently, on the mixing
mechanisms. Additional motion can be provided by the introduction of agitators - paddles, lifts,
and ribbons designed to produce greater bulk movement. Malhotra and Mujumdar [24] explored
the motion of powders in response to a single flat blade by visually tracking the displacement of a
section of tracer particles from their original position. The influence of multiple flat blades in a
cylindrical mixer was explored by Laurent and Bridgwater [25-29] using positron emission
particle tracking. A batch was run for an hour with a radioactive tracer, and a positron camera
captured the spatial coordinates and instantaneous velocities of the tracer over time. This allowed
powder flow to be fully visualized in density bins and vectors, respectively, with root mean square
displacements in the radial and axial directions broken down by particle position.
Laurent and Bridgwater found that the bladed agitator created loops of circulation. The center of
the loop of circulation moves towards the shaft as the fill increases. The types of motion
produced here are similar to those described by Mellmann in a rotating cylinder. The flow at 20%
fill is a combination of cascading and cataracting powder - some of the particles swept up by the
blades roll down the free surface, while others are flung over the shaft. The flow at 60% fill is
almost all cataracting, although some centrifuging is also evident. The advantage of using a
rotating agitator is that proper design and operation allows an agitator to simultaneously produce
several types of motion found in a drum mixer.
Since mixing occurs through relative differences in powder flow, a wide range of angular
velocities provides mixing in the radial direction. Laurent and Bridgwater discovered that
maximum radial displacement occurred between 40% and 50% fill, corresponding to the splitting
of material over and under the shaft. This bifurcation of cascading and cataracting powder is due
to the physical presence of the agitator shaft, which prevents more particles from being flung up
as well. The blocking behavior alters the powder flow, resulting in a wide distribution of angular
velocities. This is in sharp contrast to flow at 70% fill, when almost all of the particles are
cataracting over the shaft. Since the powder is moving in the same loops of circulation, the lack
of change in relative position yields little mixing. Thus, the loading fraction plays a large role in
agitated powder flow as a certain amount of void space is required for several types of motion to
occur simultaneously. The optimum fill is also dependent on the specific design of the agitator.
The same understanding of radial mixing can also be applied to axial mixing along the length of
the cylindrical blender. Although the blades are flat, individual particles can be displaced axially
during the sweeping of the blade, as they roll down the free surface, or as they cataract over the
shaft. Similar to the blocking behavior in radial mixing, particles can also move axially as they
bounce off the shaft. Once again, Laurent and Bridgwater found that fill levels between 40% and
50% provide the greatest axial dispersion. The presence of more blades produces more continuous
particle motion, which also increases the amount of axial displacement.
2.3 Experimental Mixing
2.3.1 Powder Characterization
Many pharmaceutical ingredients are described as cohesive powders, which imply the material is
highly sticky with poor flowability. This behavior is due to the dominance of inter-particle forces
over gravitational forces, causing material to aggregate. Powder flow changes with the relative
importance of these forces. Particles larger than 400 prm are generally free flowing, while those on
the order of 100 rn exhibit stick-slip flow [30]. Even the presence of such small particles in a
wide size distribution may cause the whole powder to become cohesive [20].
The application of mixing literature on granular material to drug product formulation has been
drastically limited by this key distinction - most experimental work is performed with free
flowing material while most pharmaceutical ingredients are cohesive. This discrepancy is due to
the fact that larger particles are easier to track and that most studies are not geared directly
towards the pharmaceutical industry. Thus, it is pivotal to approach the literature below with a
grain of salt and be aware of any deviations that may occur due to the cohesive nature of
pharmaceutical powders.
A wealth of metrics has been used over the years to characterize powder flow in different
industries. Historically, these indices were a way of empirically incorporating material properties
into the operation of processes [31]. However, each value was specific to a given combination of
granular material, flow geometry, and equipment design, making this characterization a poor
method for understanding fundamental powder flow and predicting future behavior when
parameters are varied.
Attempts have been made to standardize and consolidate powder characterization under the
aegis of an umbrella metric. For instance, Kaye et al. [32] captured the rheological properties of
cohesive powders by characterizing avalanching behavior in a rotating disc. Further research was
conducted to unify this testing procedure with previously used indices [33-37]. The use of these
intermediate proxies for material properties have aided R&D involving cohesive powders, but
remains restricted due to the fragmented applicability of these techniques to different operations
in the relevant manufacturing industries.
2.3.2 Analytical Setup
A typical method of characterizing batch mixing is to analyze multiple samples at each time
interval, akin to monitoring the outlet concentration over time in continuous blending. The
variance in concentration provides a metric for the degree of mixing. Blending usually causes an
initial steep drop in variance, attributed primarily to convective mixing, and then a more gradual
decrease, due to diffusive mixing [38]. Since powders are a non-ordered system, the variance
never reduces to zero, but reaches a minimum at the ideal random limit of mixing.
The biggest advance in analytical characterization of live processes was the movement from
offline techniques such as standard spectroscopy to online monitoring through light-induced
fluorescence and near-infrared spectroscopy. This evolution was made possible by technological
progress in optical equipment, enabling rapid and instantaneous feedback on performance. This
data-driven approach required greater statistical analysis but opened the doors to more quality-
focused applications such as pharmaceuticals [39]. LIF was shown to monitor dry powder
homogeneity non-invasively [40, 41] while NIR demonstrated potential in tracking quality in
both blends and tablets [42-45].
2.3.3 Experimental Characterization
While a great body of literature exists on pharmaceutical batch blending and continuous mixing
of non-cohesive particles, the intersecting field of continuous blending of cohesive powders has
historically been underexplored due to the difficulties in addressing processing scale with rapid
online analytical capabilities. In numerous batch studies, several authors [46-49] noted the effect
of sufficient shearing and fill height levels on blending performance and the applicability of this
relationship to continuous processing.
Earliest continuous blending research was conducted with cheap, industrial material from the
food and chemicals industries. Weinekotter et al. [14, 15] investigated continuous mixing of
Irgalite particle systems ranging from 0.2 to 100 pm at a maximum throughput of 300 kg/hr,
using inline analytics to determine performance via the variance reduction ratio. Both theoretical
and experimental work supported the relationship between VRR, the period of the input feed,
the mean residence time, and the Bodenstein number. Portillo et al. [50] conducted similar
convective powder mixing experiments using pharmaceutical material, noting flow patterns with
respect to horizontal angle and the importance of the number of blade passes on performance.
Berthiaux and Marikh et al. [51-53] designed a series of continuous blending experiments
around both food and pharmaceutical mixtures, capturing the relationship between operating
parameters and the hold-up weight, as well as the influence of a fluidized flow regime and the
feed consistency on the variance reduction ratio.
Pernenkil [54] performed a larger set of pharmaceutical mixing experiments, identifying mean
residence time and the time period of feeder fluctuations again as the key variables in predicting
blending efficiency. A deeper analysis also found increased particle sizes lead to higher axial
dispersion coefficients and thus increased performance. Pernenkil also made greater use of
multivariate data analysis to distinguish collinear relationships between various variables and
demonstrated its potential to characterize multicomponent blending systems.
Kehlenbeck [55] also conducted a rigorous exploration of the continuous blending of cohesive
powders, integrating the results of axial dispersion model simulations with experimental data
collected from large scale industrial mixers. The blending of calcium carbonate and maize starch
was found to correlate closely with one-dimensional transport profiles and the ratio between the
mean residence time and the period of the input feed fluctuations was concluded to be the key
determinant of mixing quality. Kehlenbeck briefly sampled the effect of different weirs at the
blender output and noted the importance of validating published results using other mixing
devices and shaft designs.
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3 Thesis Objectives
Most notable in recent continuous blending literature has been the lack of unifying frameworks
for understanding the full parameter space during blender design and operation. As shown in
Figure 3-1, the performance of continuous blenders can ultimately be attributed to one of three
factors - the physical design, operating parameters, and material properties. Physical design
encompasses variables that irreversibly set during the manufacturing of the blender and thus not
easily adjustable during operations. The primary variables of interest in this category are the
blender length and diameter as well as the details of the shaft design, from elements employed to
specific positioning. Operating parameters include process variables commonly tuned during
development and manufacturing to optimize performance, such as the shaft rotation rate, loading
fraction of the blender, and throughput of the system. Material properties comprise key values
inherent to the API and excipients employed in the formulation of choice, ranging from cohesion
to particle size and shape distributions.
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Figure 3-1: Design Framework for Continuous Blending
Following the advent of analytical techniques to effectively characterize blending in real time,
research has focused on understanding the relationships between operating parameters and the
optimal combinations for maximizing performance. While these works are quite comprehensive
for the chosen mixer and formulation, the absence of a holistic framework incorporating all three
groups of factors makes comparisons difficult. This inefficiency in reconciling isolated data sets
yields an incomplete picture of continuous blending, as differences in scale, equipment, and
materials influence the findings reported and the conclusions derived. A common methodology
and analytical framework for unifying related research is necessary in order to glean high-level
design principles from experimental data.
The application of continuous blending to pharmaceutical mixtures has also been encumbered by
the prohibitive cost of expending API for full scale manufacturing R&D. In the early stages of
pharmaceutical drug development, API synthesis can be expensive and inefficient, making it a
limiting factor during project management. At best, API committed to processing R&D subtract
directly from sales and at worst, API shortages slow the clinical trial timeline and delay
marketing approval. Care should be exercised in order to extract maximum information from a
pharmaceutical design of experiments.
This thesis aims to establish an analytical and experimental framework for understanding and
improving continuous pharmaceutical blending. This framework is meant to elucidate the mixing
behavior of pharmaceutical powders and illuminate general design principles which may be
applied in future blending research. The work extends efforts conducted by my predecessor,
Lakshman Pernenkil. By applying multivariate statistical analysis, this proposed framework
creates an iterative procedure for refining blending design and operation at minimal cost in terms
of material wasted. The objective of this framework is to quantify the effects of various
independent variables - blender design, operating parameters, and material properties - on
overall blending performance and reconcile these findings with the current understanding of
powder dynamics and continuous manufacturing.
The goal of this design of experiments then is to develop a full understanding of the relationships
between various parameters, intermediate metrics, and of course the VRR. A key consideration
throughout is the ability to leverage cheap and quick studies to inform higher-level experimental
design. The extent to which these intermediate parameters elucidate blending performance is
indicative of the processing efficiency gains which could be achieved through proper execution.
This boost in R&D productivity would play no small part in the implementation of such a
design strategy in the development of clinical stage drug candidates.
4 Theoretical Work
Previous theoretical work in powder blending was leveraged as a starting point for the design of
experiments conducted in this thesis. Given the limits in the scalability of discrete element
simulation, efforts centered on the axial dispersion equation and Markov modeling. Simulations
were then conducted at the expected experimental scale as a baseline for understanding powder
dynamics and blending performance in the given range. In this chapter, the specific
implementation is described, followed by a discussion of simulation results and the consequences
for experimental design.
4.1 Implementation of Markov Model
A one-dimensional Markov model was constructed based on the work of Berthiaux and Marikh
et al. [16, 17]. In brief, a longitudinal blender was hypothetically broken down into a series of n
chambers forming a single chain. Markov theory posits that discrete elements can move freely
between the individual compartments in the chain with probabilities governed by the general
format given by Equation (4-1). The matrix consists of a central diagonal with the probabilities
of a particle staying in the same chamber during the time interval At, with adjacent diagonals
above and below describing the probabilities of a particle moving back one chamber and forward
one chamber, respectively. The final column is an absorbing state, representing the irreversible
exit of a particle from the system.
P, 1  P1,2  0 ... 0 0 0
P2,1 P2,2 P 2,3 ... 0 0 0
0 P3,2  P33 ... 0 0 0
0 0 p 4,3 ... 0 0 0
P = ... ... ... ... ... ... ... (4-1)
0 0 0 ... Pn- 2 ,n- 0 0
0 0 0 ... p.4,nI pnl, 0
0 0 0 ... p,,-_ p,,, 0
0 0 0 ... 0 png. 1
This general model can be used to describe complex motion generated by different agitating
elements of a blender and can also be adapted to incorporate the effect of weirs in interrupting
free movement along the chain. For a blender with functionally equivalent chambers, this matrix
of probabilities can be simplified considerably. That is, the central diagonal and the adjacent
diagonals above and below can be represented by static probabilities of no movement, backward
movement, and forward movement. These three parameters encompass all possible trajectories of
a particle in the given time interval and thus must add to unity.
The mass or concentration of the material of interest along the Markov chain over time is
modeled by the vector S. In combination with a feed vector describing the forced input of
material into the system, the evolution of particle movement along each time interval can be
simulated by Equation (4-2). Over time, these vectors document the flow of material as dictated
by the given probability matrix and feed profile. In particular, the collection of concentration
values in the last chamber approximates the profile of the material as it exits the system.
S(i +1) = P[S(i) + So (i)] (4-2)
This one-dimensional Markov model was built in Matlab in order to conduct computational
simulations around blending efficiency given feeding inconsistencies. Linear Markov chain
theory implicitly assumes the fluctuations in the inflow are not significantly enough to disrupt
the steady-state regime of the local hold-up and fill fraction, only the concentration of various
materials therein. Since pharmaceutical focus is on the API as the material of interest and the
low concentration of API in the overall formulation, this simplification was acceptable.
When the feed vector is simply a Dirac delta function, the resulting exit profile is an impulse
response function, akin to an experimentally-derived residence time distribution. The simulations
can be reconciled with experimental data derived from the axial dispersion equation by fitting
Markov probability values to the given mean residence time and Bodenstein number. Figure 4-1
provides a sample experimental fit with the yielded Markov parameters. The model provided a
good fit with the open-open one-dimensional axial dispersion equation, indicating an acceptable
translation between Markov simulation data and residence time distribution experiments in
terms of understanding axial blending performance. This enabled the model to predict the system
response to any given input feed profile for the API.
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Figure 4-1: Fitting Markov Model to Axial Dispersion Equation
The Markov model thus served as a simulation package for predicting the effect of input feed
consistency on the exit profile, for any given system characterized by axial dispersion or Markov
probability parameters. The primary performance metric, variance reduction ratio, was evaluated
against a range of values for mean residence time, Bodenstein number, and feed frequency period.
Figure 4-2 shows a simulation of blending startup where the mean residence time is equivalent to
the feed frequency period, for a normalized residence time of 1. After an initial induction lag to
reach steady-state, the output profile began to follow the input feed profile, albeit with an
amplitude attenuation (variance reduction) and a phase shift matching the mean residence time.
Figure 4-3 shows the same system with more frequent feed input variation, half the original wave
period for a normalized residence time of 2. The resulting output was significantly less volatile,
indicating a higher variance reduction ratio. As discussed in the previous chapter, a blender
functions as a low-pass filter, dampening high frequency signals through homogenization but
allowing low frequency feed variation to slip through. For a given mean residence time, it
becomes increasing difficult to mix particles together the further apart they are in time and space.
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Figure 4-2: Markov Simulation, Normalized Residence Time = 1
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Figure 4-3: Markov Simulation, Normalized Residence Time = 2
The resulting variance reduction ratio at steady-state for each simulation was compiled to better
understand the relationship between blending performance, normalized residence time, and the
Bodenstein number. The results and consequences for blending and experimental design are
discussed in the next section.
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4.2 Markov Model Results
Markov simulations were conducted at a range of mean residence times, Bodenstein numbers,
and feed input periods corresponding with the work of Pernenkil [54] in order to glean insights
into blending performance. While literature has shown the general influence of each variable
with respect to variance reduction [15, 16], the simulations performed here are specific to the
range for potential experiments and the design space of interest.
Figure 4-4 shows blending performance for a blender with a mean residence time of 60 s and
variable Bodenstein numbers and feed input periods. Variance reduction ratio was plotted against
normalized residence time, the non-dimensional ratio between mean residence time and the feed
input period. A semilog relationship between VRR and normalized residence time was found,
with a performance gain of two orders of magnitude when the normalized residence time was
increased from 1 to 2, the same range demonstrated in Figure 4-2 and Figure 4-3. Increases in
blending efficiency diminish greatly beyond this range as the physical mixture hits the random
mixture limit [8, 9]. This relationship re-emphasizes the importance of feeding consistency in
blending performance and provides a simple first-order rule-of-thumb for sizing a blender once
feeding equipment has been selected and its limits understood.
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Figure 4-4: Variance Reduction Ratio during Markov Simulations
The blending performance curves were plotted separately for several Bodenstein numbers,
representing relative differences in dispersive and convective motion within the blender. Here, the
gains in performance were not as significant. Over the expected range of Bodenstein numbers,
variance reduction increased by approximately half an order of magnitude, gains which were
erased at the higher normalized residence times. The Markov simulations suggest that while
higher dispersion can boost blending efficiency, higher normalized residence times may provide a
more robust method of designing better blenders.
For another perspective, Figure 4-5 shows blending performance in terms of output relative
standard deviation, given an API feed rate of 5% ± 1%. Again, the performance gains of lower
Bodenstein numbers were completely absorbed at higher normalized residence times. The mean
residence time had to be roughly equivalent to the input feed period in order to generate relative
standard deviations below 6%, the FDA-mandated threshold for manufacturing quality. Tablet
failure rates for a given bound of ±6% from mean concentration were plotted in Figure 4-6,
assuming axial slices were directly punched into tablets. Failure rates dramatically fell to 0%
around a normalized residence time of 1.
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Figure 4-5: Output Relative Standard Deviation during Markov Simulations
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Figure 4-6: Projected Tablet Failure Rate during Markov Simulations
The Markov modeling provided a theoretical foundation for iterative design and experimental
work. In sum, the simulations suggest that the mean residence time must be greater than the
input oscillation period of the feeding equipment, with order of magnitude gains up to a
normalized residence time of 2. While Bodenstein numbers can also have a positive effect on
blending performance, the gains between higher mean residence times and lower Bodenstein
numbers overlap and become redundant at higher normalized residence times. Thus, the Markov
models indicate that higher mean residence times should be the focal point of improving VRR
along the axial dimension.
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5 Experimental Methodology
This chapter details the materials, equipment, and method of approach for blending experiments.
Blender design, choice of API, and selection of excipients were based on literature research and
standard protocol in the pharmaceutical industry, particularly the work of Pernenkil [54].
5.1 Materials
Pharmaceutical material for tablets is broadly split into two groups - the API, responsible for
pharmacodynamic behavior, and excipients, which adjust the operational or pharmacokinetic
properties of the tablet. Excipients can be sorted and added to the pharmaceutical recipe
depending on the specific purpose. For example, fillers simply provide tablets with bulk, while
lubricants coat the powder mixture to improve flowability during processing and manufacturing.
Two API and five excipients were used during the course of this research, summarized below in
Table 5-1. All materials were sealed from moisture during storage.
Material Particle Size Density
p (tm) a (pm) (g/cc)
Acetaminophen 110 - 0.267
Caffeine 196 100 0.576
DCL11 100 50 0.595
DCL14 110 70 0.641
Parteck M200 160 110 0.568
Avicel PH-102 100 - 0.378
Avicel HFE-102 100 - 0.386
Table 5-1: Material Properties
5.1.1 Active Ingredients
Acetaminophen
Acetaminophen (also known as N-(4-hydroxyphenyl)-acetamide or paracetamol) is a common
analgesic and anti-pyretic used in the treatment of headaches, pains, cold, and flu, perhaps better
recognized as the main ingredient in Tylenol. Acetaminophen was obtained from Sigma-Aldrich
as an anhydrous white powder. A slight tendency to clump during handling was observed.
Caffeine
Caffeine (1,3,7-trimethylpurine-2,6-dione) is a naturally occurring xanthine alkaloid and a well
known psychoactive stimulant. Caffeine was obtained from Sigma-Aldrich as an anhydrous
white powder. A pronounced tendency to clump during handling was noted.
5.1.2 Excipients
DCL11
Direct compressible lactose, grade 11 (DCL11) is composed of both amorphous and crystalline
forms of lactose, a disaccharide derived from the glycosidic linkage of galactose and glucose.
DCL11 particles have been spray dried to create spherical shapes, improve powder flowability,
and reduce the need for lubricants. DCL11 was obtained from DMV-Fonterra Excipients.
DCL14
Direct compressible lactose, grade 14 (DCL14) also consists of spray dried lactose in both
crystalline and amorphous forms. DCL14 has a larger mean particle size and a wider distribution
of particle sizes than DCL11. DCL14 was also obtained from DMV-Fonterra Excipients.
Parteck M200
Parteck M200 is composed of mannitol ((2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol), a naturally
occurring sugar alcohol often chosen as an excipient due to its low solubility and sweet taste.
Parteck M200 is a free flowing, high compactibility formulation of mannitol, obtained from
EMD Chemicals.
Avicel PH-102
Avicel PH-102 consists of microcrystalline cellulose (MCC) in irregular shapes and sizes to
promote compaction. Cellulose is a biopolymer chain of D-glucose units most commonly found
in nature as the structural component of plant cell walls. In pharmaceutical development, MCC
is a widely used as a filler and binder. Due in part to the particle shapes, Avicel PH-102 may not
exhibit free flowing characteristics under a high moisture environment. Avicel PH-102 was
obtained from FMC Biopolymer.
Avicel HFE-102
Avicel HFE-102 is composed of roughly 90% MCC and 10% mannitol, a novel blend intended
to improve flowability and compactibility. Given the chemical composition, Avicel HFE-102 was
expected and observed to possess powder characteristics similar to both Avicel PH-102 and
Parteck M200. Avicel HFE-102 was also obtained from FMC Biopolymer.
5.2 Equipment
An overview of the hardware used in experiments is provided below. The section begins with a
description of various elements of the blending devices, then details the powder feeder and the
near-infrared spectrometer. More common devices employed in this methodology, such as the
weigh scale and the tachometer, are not expanded here but discussed in experimental procedure.
5.2.1 Blender
A total of four blenders were constructed and utilized in the design of experiments. Blender parts
were custom-designed and fabricated by the MIT Central Machine Shop. Each blender
consisted of a shaft sitting inside a shell and capped by end plates. The blender assembly was
mounted onto a vertical plate with a heavy base. The plate also houses a 24 V DC motor that was
secured to the exposed shaft via interlocking joints. A near-infrared spectrometer was positioned
next to the analytical ports in the shell to provide real-time monitoring. A depiction of the
complete configuration is shown in Figure 5-1.
Figure 5-1: Physical Configuration of Blender
The shell and end plate are shown in Figure 5-2. The shell is composed of poly(methyl
methacrylate), with an input port on the top of the upstream end and analytical ports on the
bottom of the downstream end. The analytical ports are quartz panels which lay flat against the
inner diameter of the shell, maintaining the operational integrity of the rotating shaft. The ends
of the shell are threaded to affix the end plates. Both end plates include a central opening where
the shaft will sit and centers the shaft for rotation within the shell. Ball bearings float between
the each end plate and the shaft, enabling free rotation. The downstream end plate also contains
two weirs that serve as the outlet ports of the blender.
Figure 5-2: Blender Outer Assembly
Two types of shafts were designed for blending. The double helical ribbon shafts consist of two
concentric helices with opposite pitching - the outer helix propels particles forward while the
inner helix pushes particles backward. The original shaft is 15 cm in length and 5 cm in diameter
and made of polymeric stereolithographic resin, with steel pins connecting the ribbon structure
to the central shaft. A clearance rate of 0.5 mm was set between the shaft and the inner wall of
the shell to protect the shell from damage during operation. The same clearance rate was also
used between the two concentric helices to create a free surface for powder movement. Two
additional versions of the double helical ribbon shaft were also manufactured, both made of grade
17-4PH stainless steel. The double length version extends the shaft to 30cm in length while the
half scale version shrinks the shaft to 7.5 cm in length and 2.5 cm in diameter.
The paddle shaft consist of a series of rectangular paddles jutting out of the central shaft at a 2*
tilt to provide greater radial movement and impart a small net forward axial velocity, as proposed
by Marikh et al. [52]. Each segment of the paddle shaft contains two paddles on opposite sides of
the shaft, with each set alternating in a 90' configuration rotation from the adjacent segments.
The paddle shaft was made at the original scale of 15 cm in length and 5 cm in diameter, with a
total of 16 paddles. All four shafts are pictured in Figure 5-3.
Figure 5-3: Blender Shafts
The four shafts and three shells can be combined to form four different blender assemblies - the
original scale ribbon blender (Figure 5-4), the double length ribbon blender (Figure 5-5), the half
scale ribbon blender (Figure 5-6), and the original scale paddle blender (Figure 5-7). In all four
figures, material enters through the inlet port on the left and is propelled through the blender by
the action of the shaft. Particles pass by the analytical ports where real-time measurements are
collected before exiting through the weirs in the outlet end plate.
Figure 5-5: Double Length Ribbon Blender
Figure 5-6: Half Scale Ribbon Blender Figure 5-7: Original Scale Paddle Blender
5.2.2 Feeder
A Schenck AccuRate feeder (Tuf-Flex Series 300) was used to deliver excipients to the blender.
The feeder consisted of a hopper funneling down to a nozzle where a rotating helix or screw
dispensed powder out. The feeder sat on top of a counterbalance scale and was linked to a
feedback control system. The loss-in-weight during feeding was actively measured, allowing the
PID algorithm to adjust the shaft rotation rate to match a set mass flow rate. Using different
screws or helices, flow rates ranging from 0.1 to 15 kg/hr were achievable.
Figure 5-4: Original Scale Ribbon Blender
Figure 5-8: Schenck AccuRate Feeder
5.2.3 Near-Infrared Spectroscopy
The majority of experiments relied on near-infrared spectroscopy for analysis. When molecules
are excited by light, relaxation from higher vibrational states occurs through emission of
electromagnetic radiation in the near-infrared range. The absorbance of NIR wavelengths
provides a signature of the composition of matter in the analytical space, containing information
on both chemical identity and physical positioning. An Axsun NIR Analyzer was used to collect
NIR data in the 1350-1850 nm range. The spectrometer consists of a Class 1 laser with a flexible
detection platform and microelectromechanically tunable optical filters to rapidly measure NIR
spectra over discrete ranges.
While the NIR spectra provide indirect chemical and physical information, calibration samples
and multivariate statistical analysis are necessary to translate the readings to relevant parameters
of interest. Projections to latent structures are necessary to distill the large number of X variables
(in this case, absorbance data for 501 wavelengths) in order to glean the Y variable of interest (in
this case, the API%) from a small number of observations. Section 5.3 will cover the application
of multivariate data analysis to this thesis is broader terms, while Section 5.4.2 below will detail
the specifics of leveraging statistical techniques to translate NIR data.
5.3 Multivariate Data Analysis
Scientific research is the process of collecting observations about variables. In traditional data
collection, a large number of observations are made regarding a relatively small number of
independent variables. This creates data sets commonly described as "long and lean" - more rows
of observations than columns of variables. Such a data set lends itself well to classical methods of
statistical analysis, such as linear regression and analysis of variance. When the data is statistically
powered and variables are independent, the common scientific method of developing correlations
and models is widely accepted.
However, this luxury is not always affordable. In the age of increasingly sophisticated analytical
technology and massive servers of data, problems at hand may not be tractable with traditional
analytical tools. In particular, "short and wide" data sets are becoming prevalent - statistically
underpowered data with more columns of variables than rows of observations. Such data sets
occur often in chemometrics, the field of extracting information from analytical data on chemical
systems. As in the case of NIR spectroscopy, hundreds of variables (such as 501 wavelengths of
absorbance) may be employed to detect a single underlying chemical property (such as the API%
by mass). The data is expected to be noisy and variables exhibit different degrees of correlation
with respect to the primary Y variable of interest and other X variables.
Problems such as dimensionality and multicollinearity have been discussed for decades [56-58].
Advances in statistical analysis and computing power have allowed a variety of multivariate tools
to address such issues. Two key methods, principal component analysis and projections to latent
structures, are described in brief below. Further exploration in the literature is higher encouraged
to develop a stronger sense of the material [57-59].
5.3.1 Principal Component Analysis
Principal component analysis is a mathematical transformation which converts a set of variables
into principal components which capture the data in fewer dimensions. PCA was first proposed
by Pearson [60] and can be used to simplify and visualize multi-dimensional data in order to
discover correlations, trends, and outliers. For a given set of data, PCA determines "the lines and
planes of closest fit" by identifying the linear combinations of the variable space which yield the
least squares for the PCA fit. These orthogonal principal components explain the spread of data
while reducing the dimensionality, stripping out noise and revealing which variables move
together through their composite interaction with the principal components.
The fundamental mathematical foundation of PCA is represented in Equation (5-1). The data
set X can be separated into three factors - pre-treatments, principal components, and noise. A
given set of data is first pre-treated to give equal weighting to each variable and objectively shape
the data for analysis. Common techniques include unit variance scaling and mean-centering. The
principal components are represented by the matrix TP', where T are the scores which map the
relationship between the observations and the principal components while P' are the loadings
which carry the weighting of the variables in the principal components. This matrix contains the
least squares PCA model, while the matrix E contains the residual noise.
X =1x'+TP'+ E (5-1)
PCA is a flexible statistical process and forms the basis of numerous derivative multivariate
analytical methods, including projections to latent structures.
5.3.2 Projections to Latent Structures
Projections to latent structures leverages the mathematical foundation of PCA to find the
relationship between a set of factors X and a set of responses Y Rather than determining the
scores and loadings which maximize the explained variance in X, PLS seeks to maximize the
explained covariance between X and Y The PLS model builds on top of the PCA framework
through the addition of Equation (5-2), where the scores matrices T and U and linked through
an inner relation. PLS thus utilizes the principal components of X in order to best explain the
variability in Y.
Y =1y'+UC'+ F (5-2)
U=T+H
PLS has two separate applications in this current research. First, PLS was used to construct NIR
calibration models translating NIR spectral data to chemical composition. Specifically, PLS
modeled the relationship between absorbance values at 501 wavelengths and the API mass
percentage. Second, PLS was employed to explore the correlations between experimental
variables, such as design characteristics, operating parameters, material properties, and
performance metrics. In this application, PLS serves more as an identification tool for
determining key variables of interest which should receive greater focus in blending optimization
efforts. Both statistical methods are necessary for this work given the large number of variables
available and the limited number of observations, as detailed below in Section 5.4.
5.4 Experimental Procedure
A series of experiments were used to collect data on blending performance. The relationship
between these studies is shown in Figure 5-9. At the lowest level, fill weight experiments were
conducted by running pure excipient through the various blenders at different operating
parameters. This non-destructive processing technique gave quick estimates of space time, the
amount of time a particle spent in the blender, and fill fraction, the percentage by volume of the
blender occupied by material. At the next level, residence time distributions were conducted by
adding an impulse shot of API to a steady-state stream of excipients to determine the system
response to the API. This yielded data on the mean residence time, the average amount of time
an API particle spent in the blender, and the Bodenstein number, a measure of the variability in
mean residence time. Finally, full blending experiments were also conducted where a continuous
signal of API over time was fed to a steady-state blender to determine the VRR. When the
blending studies were repeated with different frequency feed inputs, the frequency response
provided another dimension of data on blending performance.
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Figure 5-9: Chain of Experiments
This chain of experiments yielded a host of metrics by which to evaluate the performance of the
blender in any given configuration of design, operational, and material parameters. As indicated
in Figure 5-9, these metrics can be reached with differing degrees of technical complexity, time,
and cost. While fill weight studies can be done economically and rapidly with no unsalvageable
loss of material, the intermediate metrics it provides may be less relevant to the primary metric of
concern, the VRR. On the other hand, full blending experiments give direct results but can be
prohibitively expensive to run at manufacturing or in a rigorous design set, especially with new
API that is still in development and only available in rare quantities.
This hierarchical approach to design space exploration produced data sets on primary parameters,
intermediate metrics, and the VRR, which could be collated to develop a deeper understanding
of the complex interrelationships in this process system. As proposed in the thesis objectives, this
longitudinal structure enables correlation studies between all variables of interest. Multivariate
analysis can be employed here to disentangle multicollinearity and highlight key parameters to
leverage for improving blending performance.
5.4.1 Fill Weights
Fill weight experiments were conducted by placing the blender assembly on top of a weigh scale
and running pure excipient through the system to reach steady-state operation. Mass flow rate
was adjusted through the feeder controller while the shaft rotation rate was tuned by manually
correcting the voltage supplied to the motor in order to match the reading on the tachometer.
Care was taken to configure the fill weight system such that the material interfaces were free of
direct physical connections to eliminate variability in the weigh scale readings. For any given set
of operating conditions, the weight of material in the blender was measured once steady-state
was achieved. To attain results in triplicate, steady-state was disrupted and allowed to resettle
again. The average weight was then used to calculate both the space time and the fill fraction. A
linear correction was applied to the space time to account for the relative lengths of the blender
from end to end and from input to the analytical port. This adjustment made the values more
directly comparable to those parameters ascertained from near-infrared spectroscopy.
5.4.2 NIR Calibration
Higher-level metrics were computed through API% over time, as determined via near-infrared
spectroscopy. This characterization technique requires calibration with known samples in order to
accurate interpret the spectral results. NIR calibration was conducted in each instance with
samples of the API-excipient combination that had been mixed in a V-shaped blender for 30
minutes to reach homogeneity, as per Ngai [46]. Samples ranged from 0% to 50% according to
API% by mass. NIR reflectance values were collected from each sample at 501 different
wavelengths (1350 to 1850 nm). The spectra was prepared for data analysis, following general
chemometric protocol as per Brereton [58] - conversion to unit variance scale, then application
of an 11-point first-derivative Savitzky-Golay filter and a standard normal variate transform.
This data treatment reduces noise in the chemometric signal while removing the effect of density
and ambient light on the data. The top half of Figure 5-10 shows the processed signal for a
complete set of calibration samples for caffeine and Avicel PH-102. Due to differences in the
chemical signature of the API versus the excipient, the spectra diverge in the near-infrared range
as API concentration is varied, although the extent of divergence depends upon the relative
resonance between each wavelength and the various compounds.
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Figure 5-10: Intermediate NIR Data Processing
A PLS model was assembled in SIMCA-P+ using the processed NIR data and the API% values
of the known samples. The PLS model was built using the preset algorithms to quantify the
importance of each variable to the metric of interest. The bottom half of Figure 5-10 shows the
variable importance plot for the same wavelengths. Notice that the spectra for the calibration
samples diverge more at certain wavelengths that resonate more with the chemical identity of the
API than the excipient. The PLS model attributes greater weighting to those wavelengths in the
statistical regression with respect to API%.
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Figure 5-11: PLS NIR Calibration
The result is a PLS calibration shown in Figure 5-11. The calibration can be evaluated by several
statistical metrics, including R2Y (the amount of Y variability explained by X) and Q2 (predictive
ability of the model as checked by statistical cross-validation). PLS models of NIR samples
yielded R2Y and Q2 values above 0.95 for all calibrations used in data collection, indicating
strong correlation and translation of NIR spectral data to API% values.
5.4.3 Residence Time Distribution
Residence time distributions were obtained by monitoring the outlet API% after an impulse shot
of API was administered to a steady-state stream of excipient flow. The quantity of the shot was
set to be 10% of the average weight observed at the same operating conditions during the fill
weight studies to ensure a strong data signal. NIR spectra was recorded at the analytical port
every 2 s by automated Axsun software. The duration of the experiment was set to a minimum of
twice the relevant space time to ensure the fill residence time distribution was captured. Figure
5-12 shows the sample NIR output upon PLS translation in blue dots.
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Figure 5-12: Fitting of RTD Data to Axial Dispersion Model
Blending in an axially mixed system can be modeled as one-dimensional axial dispersion using
the Fokker-Planck equation, shown earlier as Equation (2-1). When non-dimensionalized, key
parameter Bo indicates the Bodenstein number, a measure of velocity versus dispersion and the
solid equivalent of the Peclet number for liquids.
Along the length of interest, from the inlet port to the analytical port where NIR spectra is
collected, dispersion occurs both immediately upstream and downstream, resulting in tractable
open-open boundary conditions. Fogler [61] derived the solution to be Equation (5-3):
E(0) Bo ex( Bo(1 - 0)2 (-
4rv 40
The open-open solution to the one-dimensional axial dispersion model was used to characterize
the residence time distribution via two parameters - the mean residence time and the Bodenstein
number. A sample fitting in shown in Figure 5-12, where the red line delineates the axial
dispersion model overlaid on the NIR data. Mean residence time averages the duration of a
particle in the blender, while the Bodenstein number indicates the width of the distribution and
the amount of variability in particle duration over the entire range of probabilities.
5.4.4 Blending
In fill blending runs, API is constantly fed at a given frequency to a steady-state stream of
excipients in order to characterize the system response to an input signal. At these small scale
manufacturing rates, feeder technology is not yet capable of delivering an input with any more
sophistication than a constant rate. In order to reconcile the experimental work with previous
theoretical understanding, API feed was delivered manually to mimic the sine wave signals from
the Markov simulations. Four dosages were fed sequentially in ascending and then descending
order, producing a cycle of six shots - 25%, 40%, 50%, 40%, 25%, then 0%. The dosage was set
such that an overall API mass of 5% was maintained in the blender at steady-state. In the 60 s
feed frequency, API shots were 10 s apart, while in the 30 s feed frequency, API shots were 5 s
apart. Table 5-2 provides the API feed schedule for given excipient flow rates.
Excipient 30 s Feed Frequency 60 s Feed Frequency
Flow Rate Mass of API per Feed (g) Mass of API per Feed (g)
(kg/hr) 0% 25% 40% 50% 0% 25% 40% 50%
2 0.00 0.14 0.22 0.28 0.00 0.28 0.44 0.56
5 0.00 0.35 0.56 0.69 0.00 0.69 1.11 1.39
10 0.00 0.69 1.11 1.39 0.00 1.39 2.22 2.78
Table 5-2: API Feed Profiles for Blending
Feeding during blending runs continued for a minimum of 5 minutes to ensure enough cycles at
the new steady-state. Figure 5-13 shows a representative sample output, with the same ramp-up
to steady-state as the Markov simulations and a ramp-down once API feeding is discontinued.
Based on the Markov work, data collection for VRR calculation began after two mean residence
times (based on the relevant residence time distribution experiment) had elapsed. Only full cycles
of data were incorporated for VRR calculation. The red lines in Figure 5-13 mark the sample
data used in this instance to determine the output variance.
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Figure 5-13: Sample of Full Blending Data
The resulting VRR could then be recorded along with other intermediate metrics determined for
the same operational setting - fill fraction, space time, mean residence time, and the Bodenstein
number. These metrics, along with the original design characteristics, operating parameters, and
material properties, will be evaluated through close juxtaposition and multivariate data analysis in
the following chapter detailing the experimental results.
6 Double Helical Ribbon Blending Results
The experiments described in the previous chapter were conducted on three double helical
ribbon blenders. The results of each procedural set are first discussed separately with respect to
intermediate parameters of note. Data was then aggregated for multivariate analysis.
6.1 Fill Weight Experiments
Fill weight experiments were conducted over a range of mass flow rates and rotation rates, using
five excipients and three ribbon blenders. The steady state hold-up weight of powder in the
blender during continuous operation enabled calculation of the fill fraction and the space time.
The effect of design and operating parameters on these values is discussed below. Initial results
focus on 30 rpm fill weight studies conducted with Avicel PH-102 in the double length blender,
and then expand to include more data sets as more parameters are presented.
Effect of Mass Flow Rate
A sample output from fill weight experiments over the feasible range of mass flow rates is shown
in Figure 6-1. Three runs were conducted at each experimental setting, with each run result
plotted as an individual data point. Hold-up weights and mass flow rates exhibited a strong
positive linear correlation and the values were in close agreement after repeated trials. An increase
in the mass flow rate filled the blender at a faster pace, causing the fill weight and fill fraction to
increase as well. When the powder bed height rose, more powder was exposed to the mechanical
motion of the shaft, until a new equilibrium was reached.
For the given bulk density of each excipient and free volume of each blender, the fill fraction of
powder within the blender could be estimated. The action of the ribbon blender resulted in a net
forward movement of powder in the axial direction, sufficient to carry powder downstream as
new material was introduced into the blender. As a result, the fill fraction level was observed to
be relatively even along the length of the blender. The same experimental set from Figure 6-1
was used to plot fill fraction over mass flow rates, shown in Figure 6-2. A similar positive trend
was noted the two variables. Although the estimated fill fraction neglects the effect of powder
dilation due to agitation, the resulting values seemed to fit with visual evidence. The maximum
mass flow rate at which continuous steady state operations could be maintained consistently
yielded fill fractions of approximately 90%. The remainder was attributable to powder dilation
and overhead necessary to accommodate movement of material along the length of the blender.
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Figure 6-2: Fill Weight Results Converted to Estimated Fill Fraction
For the given mass flow rate and hold-up weight, the space time was also calculated. The space
time indicated the average amount of time each excipient particle spent in the blender. The
resulting values were plotted against fill fraction, as shown in Figure 6-3. Space times were lowest
at low fill levels, where the powder bed was only exposed to the movement of the outer ribbon,
which pushed powder forward towards the blender exit. At moderate levels of fill, powder was
also in contact with the inner ribbon, which pushed powder upstream, yielding a lower net
forward axial velocity and increasing the space time. At high fill fractions, the powder surface saw
more of the top edge of the outer ribbon, once again increasing net forward axial velocity and
decreasing the space time. Space time reached a broad, stable peak at around 40% fill fraction.
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Figure 6-3: Space Time vs. Fill Fraction in Ribbon Blender
Effect of Rotation Rate
Fill weight studies were extended to incorporate the effect of various rotation rates of the internal
shaft. Figure 6-4 includes fill fraction values at two additional slower rotation rates. With
reduced mechanical input, powder in the blender experienced a lower net forward axial velocity.
At the same mass flow rate, this resulted in an increase in the fill fraction. Since lower shaft
speeds caused the blender to fill up faster as mass flow rate increased, lower rotation rates
produced a smaller range of mass flow rates for feasible continuous operation.
100
90-
80-
70-
60-
50-
40-
30-
20-
10-
n-
0 2 4 6 8 10 12 14
Mass flow rate [kg/hr]
Figure 6-4: Fill Fraction vs. Mass Flow Rate for Different Rotation Rates
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Figure 6-5: Space Time vs. Fill Fraction for Different Rotation Rates
The space time for different rotation rates is plotted in Figure 6-5. The same trend described
earlier persists - low space times at low fill fractions, with a broad peak achieved at a fill fraction
of 40%. However, the lower rotation rates induce a smaller net forward axial velocity, causing the
space time curve to move upwards. Space time thus increases as rotation rates are reduced.
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The results discussed so far can also be compiled into three-dimensional graphs of estimated
intermediate parameters versus operating parameters. Fill fraction is shown in Figure 6-6 while
space time is shown in Figure 6-7. Again, fill levels increase with higher mass flow rates and
lower shaft rotation rates. Space times are relatively stable with respect to mass flow rates but
increase significantly at lower shaft rotation rates.
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Figure 6-7: 3D Plot of Space Time vs. Operating Parameters in Ribbon Blender
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The results discussed so far can also be compiled into three-dimensional graphs of estimated
intermediate parameters versus operating parameters. Fill fraction is shown in Figure 6-6 while
space time is shown in Figure 6-7. Again, fill levels increase with higher mass flow rates and
lower shaft rotation rates. Space times are relatively stable with respect to mass flow rates but
increase significantly at lower shaft rotation rates.
Effect of Excipients
The variance in bulk density across the five excipients necessitated a normalization of the mass
flow rate to yield the volumetric flow rate. Figure 6-8 shows fill weight data for all excipients
plotted as fill fraction against volumetric flow rate. Space times across all excipients are shown in
Figure 6-9. The resulting trends were in agreement across all the excipients tested. This indicated
that the first order effect of different excipients on blending dynamics could be accounted for by
correcting with the bulk density of the given material. The aggregation of fill weight data also
revealed a kink in the fill fraction curve and a more prominent peak in the space time curve at fill
levels of 40%. This was due to the double helical nature of the shaft design. The relative exposure
of powder to the reverse-pitch ribbon was maximized around 40%, causing an inflection point in
blending dynamics with respect to both fill fraction and space time.
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Figure 6-8: Fill Fractions for Different Excipients, Adjusted by Bulk Density
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Figure 6-9: Space Times for Different Excipients
Effect of Length
The fill weight data for both the original blender and the double length version was overlaid to
examine the effect of length on fill weight experiments. Figure 6-10 shows fill fraction versus
volumetric flow rate with both sets of results at various rotation rates included. The effect of
length on fill fraction was minimal, as the positive correlation with respect to volumetric flow
rate and negative correlation with respect to rotation rate are still apparent, albeit less discernible.
The variability in the fill weight data was greater for original blender studies, likely due to the
smaller scale of the experiments, which magnified the effect of noise on blending dynamics and
error on fill weight data collection.
For a more direct comparison of the effect of length on fill fraction, fil weight studies at the
same operating parameters were cross-tabulated across both blender data sets to produce Figure
6-11. Regardless of which blender was used, fill fractions were relatively consistent. A slight
tendency toward higher fill fractions in the double length blender was noted. This may be due to
minor manufacturing variability between the two shafts, and was not considered to be a
significant effect in the multivariate analysis.
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Figure 6-10: Fill Fraction vs. Volumetric Flow Rate for Different Blender Lengths
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Figure 6-11: Comparison of Fill Fraction across Different Blender Lengths
The effect of operating parameters on space time for the original blender is shown in Figure
6-12. Space times were roughly half the value of those in Figure 6-9, as the length of the blender
was halved. Again, more variability was observed within this data set, although the slight peak at
40% fill fraction was still visible. The same comparison is shown in Figure 6-13, where space
times from the original blender were linearly extrapolated with length to predict space times in
the double length blender. A strong 1:1 correlation was also observed, indicating the effect of
length was linear for fill weight experiments.
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Figure 6-12: Space Time vs. Fill Fraction for Original Blender
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Figure 6-13: Comparison of Space Time across Different Blender Lengths
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6.2 Residence Time Distribution Experiments
Near-infrared spectroscopy was used to characterize the impulse response over a similar range of
operating parameters for two APIs, five excipients, and three ribbon blenders. The resulting
residence time distributions were fitted to a closed-boundary, one-dimensional axial dispersion
equation in order to determine the mean residence time and Bodenstein number. Estimated fill
fractions from fill weight studies at the same experimental setting were leveraged to analyze
residence time distributions. This convenient proxy for volumetric flow rate provides a more
intuitive understanding of blending dynamics and enabled comparison across different excipients
and blenders. The effect of design and operating parameters, along with the materials used, is
discussed below.
Effect of Operating Parameters
Figure 6-14 shows the mean residence time with respect to fill fraction and rotation rate. The
trends bore a striking resemblance to those of Figure 6-5, with mean residence time in place of
space time. A peak was observed once more at the 40% fill level. This result was expected as both
parameters are simply hold-up times; the former for the API and the latter for the excipient.
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Figure 6-14: Mean Residence Time vs. Fill Fraction in Ribbon Blender
Effect on Shear Rate
Determination of residence time distributions also enabled calculation of the number of blade
passes, the product between mean residence time and rotation rate, which reveals the average
number of shaft rotations experienced by an API particle passing through the blender. This
parameter provides a rough estimate of the amount of mechanical shear. Figure 6-15 shows the
number of blade passes with respect to fill fraction. A peak was observed around the 40% mark.
At the given shaft rotation rates, increases in blade speed were offset by decreases in the mean
residence time, resulting in a similar number of blade passes.
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Figure 6-15: Blade Passes vs. Fill Fraction in Ribbon Blender
Effect of Excipients
The results for all excipients were aggregated to examine the effect of different excipients on
residence time distributions. No correlation was found with respect to the Bodenstein number.
The influence of fill fraction on mean residence time is shown in Figure 6-16. The trends were in
agreement with those of space time in Figure 6-9.
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Figure 6-16: Mean Residence Time vs. Fill Fraction for Different Excipients
Effect of Length
Similar results are presented for the original blender in Figure 6-17. Mean residence time values
were approximately half of those from the double length blender, reflecting the linear effect of
length on transport time. The original blender results again exhibit greater variability, reflecting
the difficulties of operating a solid continuous process at smaller scales.
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Figure 6-17: Mean Residence Time vs. Fill Fraction for Original Blender
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A direct comparison across the two blenders is shown for mean residence time in Figure 6-18
and for the Bodenstein number in Figure 6-19. Just as with space times, mean residence times
exhibited a strong 1:1 correlation with respect to length. On the other hand, Bodenstein numbers
do not seem to correlate strongly with length either.
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Figure 6-19: Comparison of Bodenstein number across Different Blender Lengths
Effect of API
Comparisons of mean residence time and Bodenstein number with respect to the two APIs used
are shown in Figure 6-20 and Figure 6-21, respectively. A strong correlation for mean residence
time and a weak correlation for the Bodenstein number were again observed.
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Figure 6-20: Comparison of Mean Residence Time across Different API
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Figure 6-21: Comparison of Bodenstein number across Different API
While the mean residence time appears to scale relatively well, the Bodenstein number does not.
This implies that the parameters and ranges used in this design of experiments provide little
control over the Bodenstein number. For the given technology, this may be a necessary casualty
of attempting to operate with cohesive material at such small scales.
Comparison to Space Time
Mean residence times and space times were compared in Figure 6-22 to determine the linkage
between fill weight studies and residence time distribution experiments. As expected, a linear
correlation exists between the two hold-up parameters.
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This relationship indicates that space times may provide a reasonable estimate for mean residence
times, provided the API% is relatively low or the bulk density of the formulation is similar to the
bulk density of the excipient. The potential exists for fill weight experiments to yield first order
characterization of blending dynamics without excessive use of material resources. The ability of
space time to predict the mean residence time can be captured through a relative mixing index
shown in Equation (6-1).
(6-1)RelMix = Mrt - Spt
Spt
A positive relative mixing value signifies that the API has spent more time in the blender than
the excipient, while a negative relative mixing value implies the API has spent less time. Higher
relative mixing was expected to indicate incremental improvement in mixing performance in
blending experiments. Figure 6-23 shows how this evaluative parameter varied with respect to fill
fraction. At low fill levels, relative mixing was positive on average but fluctuated greatly. As fill
level increased, both the value and the variability of the index decreased.
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Figure 6-23: Relative Mixing vs. Fill Fraction in Ribbon Blender
Figure 6-24: Powder Bed Surface at Various Fill Levels
The influence of fill fraction on the relative mixing index may be attributable to the position of
the powder bed surface during the impulse response. Figure 6-24 overlays the location of the free
surface (at an observed bed angle of 30*) on a cross-sectional image of the ribbon blender for fill
fraction values marked in Figure 6-23. Since the API impulse was delivered to a steady state
continuous operation, the location of the free surface determines the initial position of the API
particles and thus significantly influences their trajectory through the blender.
At fill levels of 20%, the free surface is adjacent to the lower edge of the inner ribbon. Particles
above the powder bed are more likely to be exposed to the reverse-pitch of the inner ribbon,
pushing them further upstream. This causes an increase in retention time for API within the
blender, leading to higher relative mixing values. As the fil fraction increases, the amount of
contact between the impulse shot and the inner ribbon decreases relative to excipient particles,
bringing the mean residence time back in line with the space time. Relative mixing begins to
decrease and turns negative when the API impulse experiences the top edge of the forward-pitch
outer ribbon.
Figure 6-25 splits relative mixing values by blender type. As noted for space times and mean
residence times, smaller scale blenders exhibited greater variability in repeat experiments due to
the relatively larger effect of noise and error. The largest blender maintained the greatest
consistency in relative mixing values across the range of fill fractions.
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Figure 6-25: Relative Mixing vs. Fill Fraction for Different Blenders
6.3 Blending Experiments
API was fed as a sinusoidal input to a steady state continuous system in order to determine the
variance reduction ratio. Blending experiments were conducted over a range of operating
parameters with two APIs and three blenders, using Avicel PH-102 as a representative excipient.
Results are discussed with respect to input frequency and API before multivariate analysis is
employed to quantify the effect of various key parameters on blending performance.
Variance Reduction Ratio
The ratio of input to output variance in API% over time yields the variance reduction ratio, the
key metric of blending performance. Figure 6-26 plots the actual VRR for blending trials versus
the mean residence time, with splits accordingly to the input frequency. The correlation between
VRR and mean residence time was relatively weak, given the impact predicted by previous
Markov modeling results. Variability had a greater effect on VRR than the mean residence time,
although a negative correlation with input frequency was observed.
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Figure 6-26: Actual VRR vs. Mean Residence Time in Ribbon Blender
The mean residence time, Bodenstein number, and input frequency of each blending experiment
was input into the Markov model to produce a predicted VRR. Figure 6-27 shows the actual
VRR versus predicted VRR with different APIs noted. Again, the correlation between VRR and
the key parameters highlighted by the Markov model was much weaker than expected, indicating
that other influences may have dominated in this experimental space. The choice of API itself
had a significant impact on blending, with acetaminophen runs outperforming caffeine runs by
roughly half an order of magnitude. The fact that API could be mixed better suggested that
radial mixing or shear rate should be explored. The weakness of the one-dimensional axial model
may be the failure to incorporate other relevant parameters. This hypothesis is explored in the
next section on the paddle blender.
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7 Paddle Blending Results
A subset of the experiments performed with the double helical ribbon blenders was repeated
with the paddle blender. Intermediate results are discussed in the same sequence as the previous
section before data analysis is aggregated at the multivariate level.
7.1 Fill Weight Experiments
Fill weight experiments were again conducted over a range of mass flow rates and rotation rates
using the same five excipients. Due to the lower forward axial velocity provided by the paddle
blender, shaft rotation rates were increased to 40-60 rpm in order to maintain the same scale of
operations. Initial results focus on 60 rpm fill weight studies performed with DCL14 and then
expand to include other parameters already introduced.
Effect of Mass Flow Rate
A sample output from fill weight experiments over the feasible range of mass flow rates is shown
in Figure 7-1. Three runs were conducted at each experimental setting and individually plotted.
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Figure 7-1: Sample Set of Fill Weight Results over Mass Flow Rates
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Mass flow rates and hold-up weights once again demonstrated a strong positive correlation. Yet
for the same blender dimension as the original double helical ribbon blender, the paddle blender
accommodated a narrower range of fill fractions. In Figure 7-2, fill fraction maximizes at
approximately 60%, compared to nearly 90% in all three double helical ribbon blenders. The
lower net forward axial velocity of the paddle blender limits its flexibility in handling different
scales of operation.
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Figure 7-2: Fill Weight Results Converted to Estimated Fill Fraction
While the double helical ribbon design was able to maintain a constant bed height during steady
state, the free surface was noticeably higher at the entrance of the paddle blender and fell linearly
along the axial length, reaching a minimum at the exit weir. The ceiling for mass flow rate was
reached when the paddles were no longer able to push particles forward fast enough to keep the
local fill fraction under control and the powder bed below the input port was clogged. Due to
transport rate limitations at the entrance, the maximum fill fraction of 60% denotes unutilized
processing capacity downstream. This could be corrected in future iterations by increasing the
pitch of upstream paddle blades to provide more forward push early in the blending process.
Space time was plotted against fill fraction in Figure 7-3. The simpler nature of the paddle
design yielded simpler blender dynamics. Since the blade pitch is consistent with respect to axial
length and bed height, higher forward velocities are achieved through greater exposure of powder
to paddles. The more particles available to be carried downstream, the faster the overall rate.
Thus, space time decreases as fill fraction increases. Without an inner ribbon pushing material in
the opposite direction, no broad peak exists as in the double helical ribbon profile. Space times in
the paddle blender are significantly higher at low fill fractions, approximately equivalent to the
ribbon blender in the 20-30% range and lower at higher fill fractions.
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Figure 7-3: Space Time vs. Fill Fraction in Paddle Blender
Effect of Rotation Rate
Fill weight results are plotted according to shaft rotation speed in Figure 7-4. The lower net
forward axial velocity imparted by the paddles necessitated higher rotation rates to maintain the
same manufacturing scale and reduced the sensitivity of fill fraction to shaft speed. As a result, fill
fractions showed a significantly weaker response to changes in rotation rate, as compared to the
double helical ribbon spread in Figure 6-4. The same mechanical difference is also the cause of
the tightly clustered space time curves in Figure 7-5. For the given 2* tilt of the paddles on the
paddle shaft, a wider range of shaft rotation rates was not possible. This shaft design limits the
potential design space to a narrow combination of fill fraction, flow rate, and space time, metrics
that are strongly influenced by the convective capacity of the shaft. Since the paddle shaft
emphasized radial mixing over axial mixing, flexibility in varying these parameters was lost but
could be partially restored using paddles with a wider tilt.
Figure 7-4:
0 2 4 6 8 10 12 14 16
Mass flow rate [kg/hr]
Fill Fraction vs. Mass Flow Rate for Different Rotation Rates
40
20
0 20 40 60 80 100
Fill fraction [%]
Figure 7-5: Space Time vs. Fill Fraction for Different Rotation Rates
Effect of Excipients
The volumetric normalization conducted in Section 6.1 was repeated for paddle blender results
across five excipients. The resulting fill fraction and space time plots are shown in Figure 7-6 and
Figure 7-7, respectively.
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Figure 7-7: Space Times for Different Excipients
In this instance, the effects of shaft rotation rates and excipients were not as easily
distinguishable. This may be due to the tighter grouping of intermediate metrics caused by lower
net forward axial velocity as well as the greater effect of powder dilation in this system. The
positioning of the paddle blades to increase radial motion will also increase powder dilation,
decreasing the effective bulk density of the passing material. To the extent to which different
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excipients experience different degrees of dilation, different blending dynamics would occur. The
clustering of results indicates that bulk density values and any parameters derived thereof would
be less reliable in paddle blending models. The reduced sensitivity of intermediate parameters to
easily adjustable macro-scale parameters once again leads to weaker control of the system.
7.2 Residence Time Distribution Experiments
NIR was employed to characterize impulse responses for both caffeine and acetaminophen in
Avicel PH-102 over a range of operating parameters. Mean residence times and Bodenstein
numbers were compiled against calculated fill fractions from the fill weight studies presented
above. Key relationships are discussed below while the entirety of the data set was abstracted into
the multivariate analysis to follow.
Effect of Operating Parameters
Figure 7-8 shows the mean residence time with respect to fill fraction. As with the space time
plots in Section 7.1, mean residence times decreased with increasing fil fraction. The lack of
reverse axial motion led to a narrower range of observed values than found with the ribbon
blenders. No strong correlation was observed with respect to the shaft rotation rate.
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Figure 7-8: Mean Residence Time vs. Fill Fraction in Paddle Blender
Effect on Shear Rate
In Figure 7-9, blade passes are negatively correlated with fill fraction. The higher number of
blade passes at lower fill fractions is attributable to the longer mean residence times, which
exposes API particles to more shearing during the blending process. The linear response is again
due to the simpler nature of the paddle design. Without the complex dynamics of the double
helical ribbon, the number of blade passes can now be increased by lowering the mass flow rate.
This feature provides an operational hedge as the system ramps up to steady state - material
flowing through during a transient state (at lower fill fractions) will experience more shearing
and mixing in the radial direction. Despite a lower range of mean residence times than the ribbon
blenders, the paddle blender generally produced a higher number of blade passes due to higher
operating shaft rotation rates.
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7-9: Blade Passes vs. Fill Fraction in Paddle Blender
Effect of API
Juxtaposition of mean residence times and Bodenstein numbers with respect to caffeine and
acetaminophen are shown in Figure 7-10 and Figure 7-11, respectively. Similar to the findings in
Section 6.2, a strong correlation was observed for mean residence time and a weak correlation for
the Bodenstein number. Mean residence times were more consistent regardless of API used. This
independence between API and axial dispersion seemed to be evident in both the ribbon and
paddle blender designs.
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Figure 7-11: Comparison of Bodenstein number across Different API
Comparison to Space Time
Mean residence times and space times were fairly consistent, as shown in Figure 7-12. The
relative mixing index was also calculated and plotted against fill fraction in Figure 7-13.
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The relative mixing index indicates that the paddle blender produced less drastic differences
between space times and mean residence times. While the index ranged from under -40% to over
100% in the double ribbon design, paddle blender experiments yielded values between -10% and
20%, a much smaller range of variation. The absence of an inner ribbon significantly reduced the
dependence of the relative mixing index on the fill fraction.
7.3 Blending Experiments
Variance reduction ratio experiments were conducted with caffeine and acetaminophen, again
using Avicel PH-102 as a representative excipient. A cursory two-dimensional analysis is shown
in this section, while a higher level statistical examination is presented in the next chapter.
Variance Reduction Ratio
Figure 7-14 plots the experimentally derived VRR values against mean residence times obtained
at the same settings, with data subdivided by shaft design. As noted earlier, the ribbon blenders
produced a much wider range of mean residence times with a more limited effect on the actual
VRR than expected from Markov modeling. The paddle blenders, on the other hand, were able
to produce blending performance on par with the ribbon blenders even within the narrower band
of mean residence times allowed by the operating parameters, as shown in Figure 7-15.
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This once again suggests that the parameters of the Markov models - mean residence time,
Bodenstein number, and period of input feed fluctuations - were insufficient to characterize
these continuous blenders. Given the one-dimensional nature of the axial dispersion framework
and the drastic difference in radial mixing between the ribbon blenders and the paddle blender,
the inability of models in literature to incorporate shear into predictions appears to be a
significant weakness in the current context.
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Figure 7-15: Actual VRR vs. Markov-Predicted VRR in Paddle Blender
Figure 7-16 summarizes the same data set with respect to blender type (ribbon vs. paddle on the
same original scale) and API (acetaminophen vs. caffeine). The bar height indicates average VRR
obtained across all operating parameters within the blending group while the spread shows the
standard deviation. As discussed in Section 6.3, the ribbon design produced significantly better
blending performance when acetaminophen was the API rather than caffeine. The paddle design
was able to match blending performance with acetaminophen and also raise the VRR in caffeine
experiments up to a similar level. This suggests that the paddle blender provides a more robust
platform for handling the differences between caffeine and acetaminophen. The increased radial
mixing and greater number of blade passes appear to correlate with better blending performance
in multiple APIs.
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Figure 7-16: Blending Performance by Blender and API
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8 Implications for Process Design
This chapter explores the implications of the presented results on process design in continuous
pharmaceutical blending. First, multivariate analysis was performed to parse the effect of various
variables on mixing performance and characterize the influence of physical design, operating
parameters, and material properties on blending. Next, the findings are encapsulated into a design
framework for future research. Finally, potential applications for this work are detailed.
8.1 Multivariate Analysis
The large data set and the exhaustive number of parameters render traditional two-dimensional
graphical analyses incomplete. Variables of interest such as the Bodenstein number and the
number of blade passes could not be controlled during the design of experiments due to its
complicated interaction with parameters that were directly adjusted. In order to isolate the effect
of any one factor, other variables must be corrected for. Multivariate analysis was used to separate
overlapping influences and identify the extent of correlation between each individual parameter
and the primary metric of performance, VRR. Figure 8-1 provides the degree of linear correlation
between relevant variables and the log-adjusted VRR for all double helical ribbon blending
experiments. Unit variance was employed to normalize the range of values of each parameter
during the set of experiments.
This technique quantifies the effect of each parameter through multivariate linear regression to
determine the individual contribution to blending performance. The correlation value, along with
the error bars, provide a first order estimate of blender sensitivity to each variable over the range
used in the experimental data set. The result is a normalized comparison which allows an "apples
to oranges" translation with respect to the key performance metric - variance reduction.
The parameters are sorted from greatest positive correlation to greatest negative correlation.
When variables on the top increased in value, the variance reduction ratio tended in increase as
well. When variables on the bottom increased in value, the VRR tended to decrease instead.
Parameters in the middle of Figure 8-1 exhibited comparatively little net effect on blending
performance. The greatest influence on blending dynamics was the choice of API. The use of
acetaminophen rather than caffeine resulted in a statistically significant increase in VRR,
reiterating the finding of Figure 6-27. Other parameters which demonstrated a strong correlation
included the relative mixing index, the Markov-predicted VRR, the number of blade passes, the
Bodenstein number, and the input feed frequency.
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Figure 8-1: Multivariate Correlation of Parameters to VRR in Ribbon Blenders
Experimental level Components R2X R2Y Q2(cum)
Fill weights 1 20.2% 26.3% 22.3%
Residence times 2 38.8% 53.7% 45.1%
Blending 1 19.3% 62.9% 59.3%
Figure 8-2: Goodness of Fit with Experimental Level
Multivariate analysis improves as the proxy experiment approaches the complexity of the actual
process. Figure 8-2 shows the goodness of fit to the primary metric as data from additional
experimental levels are included in the analysis. The correlative strength of the data, represented
by both R2Y (amount of Y variability explained by X) and Q2 (predictive ability of the model as
checked by statistical cross-validation), increases significantly. With the entire data set employed,
multivariate analysis explains approximately 60% of all variability observed in the VRR. While
this value appears low when contrasted to standard two-dimensional correlations, it is quite
comparable to other applications of multivariate analysis, especially given the number of
parameters involved and the reliance on a spectroscopic model.
Note that although lower level experimental data (fill weights and residence time distributions)
did not sufficiently account for the variation in blending performance, each level of experiments
added significantly to the correlative strength of the data set. Indeed, many of the influential
factors identified in multivariate analysis - the relative mixing index, the Bodenstein number, the
number of blade passes, and the Markov-predicted VRR - were available for characterization
with a relatively small expenditure of API. This suggests that once a general process framework
has been established, key intermediate metrics may be used to improve process performance in a
more timely and cost-effective manner.
Following standard protocol for projections to latent structures, the model provides a broad
glimpse of the first-order effect of each parameter on the VRR. However, it is worth noting that
the mathematical manipulations in this model inherently assume linear correlations between
both X and Y variables. To the extent to which nonlinearities exist, systematic inaccuracies will be
embedded within the resulting calculations. Care should be taken to linearize parameters
whenever foresight allows. For instance, the VRR was log-adjusted for multivariate analysis due
to correlations noted in the Markov computations. Another example is the fill fraction, where
nonlinearities were observed in the ribbon blender data as shown in Figure 6-23. A quick dummy
variable such as Equation (8-1) can be constructed as a substitute for multivariate modeling.
Figure 8-3 shows the analysis repeated with a linearized fill fraction parameter.
Fill ,.ear = |Fill-4%| (8-1)
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Figure 8-3: Multivariate Correlation of Parameters to VRR, Fill Fraction Linearized
With this dummy linearization, the correlation of the fill fraction to the VRR increases by
approximately 50%. The original nonlinear scale of the fill fraction understated its true effect on
blending performance. The all-encompassing nature of PCA and PLS analysis enables the
observer to easily determine directionality and parse first-order effects, but this simple check
demonstrates that further scrutiny is always recommended. Multivariate analysis serves as a key
statistical tool, but the shotgun approach does not replace the precise experimental scalpel.
The paddle blender results were added into the multivariate analysis to produce Figure 8-4.
While most parameters maintained a similar relationship to log VRR, the use of the paddle shaft
correlated with a small boost in blending performance while the ribbon blender correlated with a
decrease in VRR. This finding agrees with the earlier analysis summarized in Figure 7-16, which
showed that the paddle design improved blending performance of caffeine experiments.
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Overall, the correlations calculated through multivariate analysis support the two-dimensional
relationships observed earlier. The Markov-predicted VRR and the input feed frequency had a
significant correlation with the actual VRR, as anticipated by the Markov model. The design of
experiments elucidated a number of other key parameters, including the choice of API, number
of blade passes and fill fraction. Moreover, the multivariate analysis revealed the quantitative
relevance of each variable, providing a standard for comparison and a basis for further design
improvements. The relationships tested served as a roadmap for increasing blending performance.
By increasing positively-correlated parameters and reducing negatively-correlated parameters, a
similar design of experiments can strategically and systematically boost the efficiency of any
given blender.
--
F-
8.2 Design Principles for Continuous Blending
The results presented above suggest several design principles for improving continuous blending
in the pharmaceutical context. This section outlines key findings from this research and the
potential implications for future blending design and optimization. The following discussion
attempts to summarize principles which may be applied in the range of conditions explored.
8.2.1 Physical Design
Experimental literature commonly employs one-dimensional models such as the axial dispersion
equation and Markov chains as a theoretical basis of comparison against empirical data. Given
computational limitations on applying more sophisticated techniques such as discrete element
method simulations, this represents the current state of practical analysis. These frameworks can
also serve as predictive models during initial design of continuous blenders. While the emphasis
on mean residence time as a design metric was shown here to be prudent, caution should taken to
ensure radial mixing is adequate when theoretical models are often blind to this requirement.
When possible, multivariate analysis of experimental data can augment theoretical frameworks in
the absence of a tractable three-dimensional model of mixing.
Focus on Mean Residence Time
Chapter 4 detailed simulations exploring the effect of input feed frequency, mean residence time,
and the Bodenstein number on mixing performance within the one-dimensional Markov chain
and axial dispersion paradigm. The results indicate that periods of input feed fluctuation are a
significant detriment to blending homogeneity. Both the mean residence time and the
Bodenstein number can improve performance, although any gains due to lower Bodenstein
numbers can also be captured at higher mean residence times. In particular, the mean residence
time should be 2-3 times greater than the longest expected time period of input feed
inconsistency in order to maximize the variance reduction ratio.
This finding was validated by multivariate analysis highlighting the positive correlation of mean
residence time and the Markov-predicted VRR with actual VRR from experimental runs. The
rule of thumb has also been supported in previous literature [15, 55] and easily determined due
to the current emphasis on one-dimensional axial models. Nonetheless, a proper understanding
of feeding limitations would allow mean residence time to be a primary design metric.
Residence time distribution results in Sections 6.2 and 7.2 also noted difficulty in reproducing
Bodenstein numbers at the same operating parameters in different blenders with different API,
suggesting that the Bodenstein number is also a harder target metric to control in processing.
This may be a result of employing cohesive particles at a smaller manufacturing scale. Improved
radial mixing may address this issue and make the Bodenstein number less unwieldy to manage,
unlocking its potential as a design metric.
Radial Mixing for Robust Processing
The ability of the paddle shaft to yield more robust performance with respect to different API
indicates the importance of radial mixing in the context of cohesive pharmaceutical powders.
Given the use of one-dimensional characterization techniques, this factor may be overlooked. In
the shorter operating timeframes of continuous blending, radial mixing is equally critical to
achieving adequate performance. Abel [62] noted in smaller scale discrete element method
simulations the drastic difference in radial mixing and performance between paddle blenders and
ribbon blenders.
When simulations of radial motion are not available, this principle needs to be over-engineered
into the blender design. Adjustable attachments such as paddles can be calibrated to provide
enough radial movement without sacrificing too much axial convective capacity. This would
require experimental optimization using operating metrics. The number of blade passes was
shown in this research to be a useful proxy for extent of shear and a strong positive influence on
blending performance.
Iterative Design using Multivariate Analysis
While design principles cannot be applied in every context, the tools employed in this research
can be deployed in any processing design space or range of conditions. Multivariate analysis has
been effective in characterizing systems with a large number of highly correlated variables and
costly experiments, a common problem in pharmaceutical R&D. In this research, multivariate
analysis has validated the use of the paddle shaft to reduce performance variability with respect to
API and highlighted several parameters with the greatest effect on overall blending.
In this design space, material properties and operating parameters were found to have a more
significant effect on performance than design factors such as blender length and diameter. This
presents an opportunity to boost processing in the short-term by changing the formulation or
making operational adjustments, but the same path to optimization may not be true in a different
design space. Multivariate analysis provides first order system mapping to understand the context
and implications of the parameter space in question.
8.2.2 Operating Parameters
While various operating parameters have been studied extensively in blending literature, this
research has gathered both practically adjustable parameters and intermediate metrics in an effort
to understand the interdependence between these variables and their overlapping effect on the
performance of the blender. Fill fraction was found to be an easy metric to optimize, while other
metrics such as the relative mixing index and number of blade passes were determined to be
valuable proxies for understanding powder dynamics. Most importantly, these parameters can be
characterized without full blending runs, limiting the use of API in the high-cost environment of
pharmaceutical R&D.
Optimize Fill Fraction to Maximize Performance
Chapters 6 and 7 detailed the effect of fill fraction on space time, mean residence time, and the
number of blade passes and noted that peaks occurred. In the ribbon blenders, these parameters
reached their maximum at a fill fraction of 40-50%, where the powder bed surface experiences
agitation from both the inner and outer helix. In the paddle blender, a lower fill fraction of 20-
30% achieved more shear. Given the influence of mean residence time and the number of blade
passes on blending performance, it was not surprising to see that fill fraction also had a
significant effect.
The proper fill fraction to maximize mixing depends on the mixing elements in the blender. In
low-shear systems such as the ribbon blender, the appropriate fil fraction has been found to be
near the 50% mark, as Laurent and Bridgwater [25-29] demonstrated the importance of the
central shaft in bifurcating powder movement. In high-shear systems such as the paddle blender,
the optimal fill fraction is expected to be at the lower end where axial velocity is lower and the
frequency of blade passes is higher. In any case, the fill fraction can be adjusted via the mass flow
rate and shaft rotation rate and the optimal level determined through fill weight studies.
Intermediate Metrics Provide Cost-Effective Insight
Strong correlations were observed between blending performance and several intermediate
metrics - mean residence time, relative mixing index, and number of blade passes. These variables
provide insight into powder motion through the blender but also serve as metrics for optimizing
operating conditions. These metrics can be characterized with minimal use of API as residence
time distribution experiments are performed rather than full blending runs. In fact, space times
could be used in lieu of mean residence times for even greater savings. The research conducted
suggests that these intermediate proxies are effective from both an experimental and cost
perspective.
The utility of intermediate metrics demonstrates the potential of lower level experiments as
substitutes for larger processing runs in the face of time or cost constraints. Fill weight studies, in
which only excipients are used and recycled, and residence time distribution experiments, where
only a small bolus of API is necessary, were shown to characterize system performance relatively
well in the absence of actual VRR data. This suggests that intermediate metrics may become an
acceptable characterization shortcut once a design space framework has been established.
8.2.3 Material Properties
While physical properties such as bulk density can be measured and accounted for in blending
operation, other material properties cannot be addressed so easily. The ability of macro-scale
parameters to adjust for micro-scale differences depends on a holistic understanding of their
interrelationship with respect to blending performance. The choice of API had a clear effect on
VRR during ribbon blender experiments but was found to be minimized by the use of the paddle
blender. This suggests that the iterative design framework discussed above can be a powerful tool
for both identifying and addressing the influence of material properties on blending.
Robust Design Reduces Variability Due to Material Properties
The choice between caffeine and acetaminophen was the most influential variable in the
performance of the ribbon blender, as noted in Section 6.3 and the multivariate analysis above.
Given the small particle sizes and cohesive nature of pharmaceutical powders, factors such as
agglomeration may be of greater import here than in continuous operations in the food or
chemicals industry. This problem has been compounded by the wealth of metrics used to
reconcile the micro-scale parameters of materials with empirical data, resulting in confusion and
poor comparability.
However, multivariate analysis can address this performance variability by quantifying the extent
of the problem and identify potential parameters to mitigate the effect. This creates two distinct
methods of improving the design - improve the robustness of the operation by incorporating a
safety factor to offset the performance drop or devise new shaft elements which may boost the
values of those positive parameters. In this research, longer blenders and the use of the paddle
shaft both improved the robustness of the blending operation with respect to the API used.
Processing as a Viable Characterization Technique
Beyond the use of multivariate analysis to troubleshoot and optimize operations, the established
data set also seeds further exploration of the effect of material properties on blending. The
sophistication of multivariate data analysis allows for continual iteration and refinement in the
design of experiments to characterize higher order effects. Once the physical effect of blender
design and operating parameters have been benchmarked, the additional impact of choices in
API and excipients on mixing performance can be understood. In the same way that NIR data
enables the multivariate analysis conducted above, these correlations serve as a second layer of
foundation for aggregating the effect of other variables on the primary metric of interest. In a
highly interdependent system with collinear parameters, a multivariate approach creates highly
levered experiments when fully independent single-variable searches may not be possible.
Once the fundamental physical relationships have been resolved, new designs of experiments can
fix key parameters such as fill fraction, volumetric flow rate, and the number of blade passes in
order to minimize their effect on blending performance and facilitate experimental expansion
into new variables of interest such as different excipient formulations. These higher order effects
can now be discerned with the clearer resolution provided by the data discussed in the previous
chapters. Multivariate analysis thus yields a more direct form of characterization methodology -
the quantitative effect of the material on the end metric in question. This technique requires a
higher degree of statistical rigor, but ultimately provides a stronger bridge between various
characterization and performance metrics in cost-sensitive fields such as pharmaceutical research
and development.
8.3 Research Expansion Strategies
The design principles outlined above can be applied and extended in future research in the field
of pharmaceutical blending. The high-level roadmap serves as a powerful structure for expanding
the parameter space to include newer and more sophisticated variables. Moreover, existing data
can be leveraged as a statistical foundation for multivariate analysis, allowing later experiments to
be conducted with greater cost-efficiency. Potential avenues for future work are discussed below.
Optimize Physical Design with Intermediate Metrics
Given the statistical linkages between blending performance and intermediate metrics such as
space time, mean residence time, and the number of blade passes, optimization of physical design
parameters can be conducted at faster speeds with fewer resources. The use of fill weight and
residence time distribution experiments as the primary methodology enables greater recycling of
pharmaceutical material and reduces the use of API in process R&D. In this paradigm, full
blending runs would be performed only as confirmation of design space optimization.
This strategy can be extended to specific details of physical design, such as the selection and exact
positioning of shaft elements. The design structure proposed in this thesis creates a framework
which enables the exploration of the increasing minutiae of continuous pharmaceutical blending
while maintaining a rigorous methodology with a theoretical and empirical basis. This line of
research would thus bridge the gap between experimental blending and sophisticated simulations
such as discrete element method.
Characterize the Effect of Material Properties on Processing
As an example of statistical leverage, a small course of experiments was designed to focus on the
effect of other excipients on blending performance. Using the correlations for design and
operating parameters built above, Figure 8-5 shows the additional effect of these materials on the
VRR. Here, the Markov-predicted VRR and the input feed frequency continue to have a similar
effect on performance, but the effect of acetaminophen and caffeine has been muted by the larger
impact of switching excipients. Avicel HFE-102 appears to have a positive influence on mixing,
while DCL11 has a negative effect and DCL14 was net neutral to blending performance. This
suggests that certain material properties of Avicel HFE-102 promote mixing while some of those
inherent to DCL11 do not. This design space study thus guides further exploration of potential
interaction between material properties and processing metrics, providing a quantitative yardstick
against which characterization data can be better understood.
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Figure 8-5: Multivariate Correlation of Parameters to VRR, Extending to Excipients
This iterative approach towards a deeper system mapping of higher order effects demonstrates
the power of multivariate analysis. This statistical implementation broadens the design space by
covering a greater number of variables and values and deepens the understanding of complex
system relationships by untangling dimensionality and multicollinearity problems. This strategy
can be employed to tackle more discrete effects of material properties - such as the difference in
performance caused by changes in particle size distribution or cohesion. The statistical leverage
provided by this multivariate methodology enables proper experimental design to characterize
the individual effect of these micro-scale parameters in a rigorous manner.
Extend Research Methodology to Other Mixing Processes
While the focus of this thesis has been on dry powder pharmaceutical blending, other processes
in pharmaceutical manufacturing can have a significant positive or negative impact on drug
quality and overall homogeneity. The theoretical and experimental methodology presented in this
thesis can be extended to similarly characterize these processes. In particular, melt extrusion and
material transport are two pharmaceutical steps where the transition from batch to continuous
operations may have critical implications for API homogeneity. Both can benefit from a more
rigorous understanding of the influence of design parameters on drug quality.
Bell recently explored the potential of applying melt extrusion to pharmaceutical manufacturing
[63]. In a series of experiments with a novel pharmaceutical API, Bell noted that the twin screw
design of the commercial extruder imparted a mixing motion during the melting process and
used residence time distributions to model temperature-driven degradation. While the potential
exists for melt extrusion to eliminate other mixing steps, further research is necessary in order to
examine the consistency of homogeneity at the scale of interest and the process robustness within
a larger design space that includes other formulations.
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9 Multivariate Analysis of Pharmaceutical R&D
With the continued difficulties of the pharmaceutical industry (briefly outlined in Chapter 1),
recent discussions about the future of the industry have centered on the role of research and
development spending. The increasing cost of drug discovery (on both an absolute and per new
molecular entity basis) has led to a myriad of opinions and approaches. In February 2011, two
leading chief executives announced divergent strategies in their annual earnings conference calls
[64]. Merck CEO Ken Frazier refused to make cuts to drug R&D, citing a focus on long-term
profitability, while Pfizer CEO Ian Read promised to slash spending on internal R&D and
instead repurchase outstanding stock. In the days after those statements, Merck stock dropped
2.7% while Pfizer shares rose 5.2%. Investors appeared to punish Merck for maintaining R&D
spending and reward Pfizer for cutting its drug discovery budget.
9.1 Background
The product development process in the pharmaceutical industry is long and costly. Due to the
regulatory hurdles necessary to protect consumer safety, the branded prescription drug industry is
viewed as one the most capital-intensive sectors of the market. Figure 9-1 outlines the drug
development process as per the Pharmaceutical Research and Manufacturers of America [65].
Potential drug candidates are first identified through chemical targeting and testing, then sent
through preclinical trials in animals to gauge safety and efficacy in an indication of interest. If the
initial results are promising, an Investigational New Drug application is submitted to the FDA.
Following clearance, clinical trials begin in humans. Over three phases of clinical trials, the
pharmaceutical company attempts to statistically prove the safety and efficacy of its candidate in
the population segment the proposed indication is geared towards. Upon completion of these
trials, the data is compiled and submitted in a New Drug Application for FDA review. An
approved drug will then be manufactured at scale and marketed for sale.
Drug development is expensive due to the chance of regulatory failure and the cost of clinical
trials. Of the host of drug candidates identified in early discovery, only a miniscule portion makes
it to the market. In 2003, DiMasi et al. collected data from 10 pharmaceutical firms, calculated
the success rates and costs of clinical trials, and determined the price of drug development to be
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$802M per new drug [66]. In 2011, Adams and Brantner replicated the costing methodology
with publicly available data and reached an updated figure of over $1B per new drug [67].
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Figure 9-1: Overview of the Drug Development Process
The high cost of clinical trials has significant ramifications for drug development. Vernon [68]
noted that costs have increased as Phase III clinical trials are increasingly designed to detect
statistically significant efficacy differentials between a drug candidate and a comparator, rather
than against a placebo. This higher standard requires greater statistical power in the form of more
patients, adding to R&D investment and lowering profit margins and R&D intensity.
Despite the soaring costs of research and development, clinical trials are a necessary financial
burden in order to obtain marketing approval for a new drug. A new product often experiences a
ramp-up in sales for several years following launch before reaching a peak level. This peak level
can be sustained for a number of years before competition from newer products and patent
expiration cause a ramp-down in sales. This natural life cycle of a drug product leads to high sales
and profits for a relatively short window. Sengoku [69] notes the prevalence of this cycle even as
R&D productivity may decrease. Pharmaceutical companies must thus continually bring drug
candidates out of the pipeline and into the market in order to maintain profitability.
9.2 Scope
Did the market respond appropriately to the Merck and Pfizer R&D spending announcements?
In this chapter, multivariate analysis is conducted on historical financial data in order to quantify
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the influence of R&D spending on industry growth. This work looks at the broad sector
perspective in an effort to understand how investors should react to management guidance on
R&D spending. The focus of this analysis is on historical correlations between R&D and firm
performance and potential signals conveyed by changes in the drug discovery budget.
While financial performance can be measured in a variety of ways (price to earnings multiple,
profit margin, and market capitalization come to mind), the most direct impact of research and
development on financial metrics is support and growth of revenue levels over time. As R&D
sustains the drug pipeline and brings new products to market, this effect will be recognized in
new sales which either bolster flagging brands reaching patent expiration or boost revenue to
even higher levels. Thus, the annual growth rate in revenue is an appropriate reflection of the
success of a company pipeline and ultimately the choice to invest in R&D, although selection of
promising candidates and differing rates of R&D productivity will also have an impact.
Given that R&D expenditure is necessary in order to bring a drug product to market, the
relationship between R&D spending and revenue growth for a small pharmaceutical firm with
only one or two drug candidates is self-evident. This correlation is expected to be strong during
the growth phase of any pharmaceutical firm. The multivariate analysis thus focuses on mature
companies with a diversified portfolio of drug products which need to be replenished over time.
As these firms budget their R&D spending each year, does the resulting allocation have an effect
on financial performance in the years to come?
9.3 Methodology
Pharmaceutical and biotechnology companies were identified by market capitalization and
screened for financial stability and revenue maturity. Recurring revenue growth rates of over 40%
per year indicated that a firm had a relatively small product portfolio and was in a growth phase
as a few new products ramped up in sales. These timeframes were excluded from the analysis as
discussed in the scope. Firms with a recurring history of significant mergers and acquisitions were
similarly excluded as organic revenue growth due to successive drug approvals was difficult to
determine as financial statements were consolidated.
A total of 11 large-cap pharmaceutical and biotechnology firms met the established criteria.
Financial data from the selected group was collected from publicly available SEC filings - annual
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reports, 10-K forms for domestic firms, and 20-F forms for foreign firms - going back 20 years
to 1991. R&D spending was determined as a percentage of net revenue in the given year while
compound annual growth rates (CAGR) of revenue were calculated along several time horizons,
from one to seven years. The resulting data set was analyzed using SIMCA-P+ as per the
statistical methodology outlined in Chapter 5.
9.4 Results
Figure 9-2 shows R&D spending as a percentage of net revenue against revenue growth in the
following year for all the selected firms in the given time period. R&D spending ranged from
roughly 8% to 31% while revenue growth ranged from -18% to 29%. While any sudden decrease
in R&D spending is not expected to have an immediate impact on financial data, the data
suggests a weak positive correlation between R&D spending and 1-year revenue growth.
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Figure 9-2: Comparison of Revenue Growth vs. R&D Spending
Next, R&D spending was compared to revenue growth over increasingly longer time horizons.
Figure 9-3 shows the first order relationship between annual growth and R&D spending from
the 1-year period to the 7-year window. In the year after the given drug discovery expenditure,
revenue growth increased by 0.45% for every additional percent of net revenue spent on R&D.
Over longer time horizons, this ratio increases gradually up to 0.834 for the 7-year revenue
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CAGR. This trend suggests that R&D spending has an increasing influence on future revenue, as
expected due to the extended timeframe of drug development and approval. The regressions
indicate that R&D spending correlate well with top-line performance even 7 years out.
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Figure 9-3: Simple Linear Regression between Revenue Growth and R&D Spending
Multivariate analysis was conducted with PLS models of each CAGR constructed around R&D
spending data, with the year accounting for annual differences in pharmaceutical consumption
and dummy variables representing each company to incorporate differences in pipeline success
and productivity. The goodness of fit of these PLS models is summarized in Figure 9-4.
Model Components R2X R2Y Q2(cum)
CAGR1 1 12.6% 18.7% 10.0%
CAGR2 1 13.3% 27.9% 20.7%
CAGR3 1 13.9% 37.8% 32.9%
CAGR4 2 25.7% 49.7% 42.0%
CAGR5 2 25.8% 58.3% 51.2%
CAGR6 2 30.5% 67.4% 62.1%
CAGR7 2 30.9% 77.6% 72.7%
Figure 9-4: Goodness of Fit with Future Revenue Growth
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R2Y (amount of Y variability explained by X) and Q2 (predictive ability of the model as checked
by statistical cross-validation) both increased at longer time horizons, indicating high correlative
strength between parameters. The specific correlation of each CAGR model to R&D spending is
shown in Figure 9-5. The data again suggests a high degree of statistical correlation between
R&D spending and revenue growth over the next 7 years.
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Figure 9-5: Correlation between R&D Spending and Revenue Growth
Differences between individual firm performance and the sector-wide relationship between
revenue growth and R&D spending were attributed to each firm through lumped parameters in
the PLS model. Figure 9-6 shows the correlation between pharmaceutical firms and revenue
performance once R&D spending was accounted for. These values of correlative strength are
comparable to those of Figure 9-5 and indicate that companies used their R&D expenditure to
obtain very divergent financial results.
These correlations can be interpreted as R&D efficiency with respect to revenue growth, a gauge
of research productivity over the last 20 years. The R&D productivity metric can vary with the
success rate of pipeline candidates, a function of positive trial selection and effective scientific
application, but also varies with the attractiveness of the market opportunity in the targeted
product indications. For instance, Amgen and Biogen Idec both scored high on productivity at
least in part due to their focus on biotechnology products, a newer segment with less competitive
pressure and more commercial opportunities for novel therapeutics.
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Pharmaceutical Firm R&D Productivity
Amgen 0.263
Biogen Idec 0.094
Novo Nordisk 0.088
Novartis 0.028
Eli Lilly 0.009
Abbott -0.007
Merck -0.039
AstraZeneca -0.044
Sanofi -0.094
GlaxoSmithKline -0.101
Bristol-Myers Squibb -0.200
Figure 9-6: Multivariate Analysis of R&D Productivity by Firm
On the negative end of the spectrum, Bristol-Myers Squibb has shown poor productivity by this
metric. While R&D spending has steadily increased from 9.3% in 1991 to 19.4% in 2009,
revenue has stagnated in the last decade for an overall CAGR of 3.3%. The PLS models also
noted a slight negative correlation of -0.071 with respect to year, a potential reflection of
declining R&D productivity across the industry.
9.5 Discussion
The correlation between R&D spending and revenue growth appears to be historically strong.
Higher R&D spending has on average yielded greater top-line growth over the last 20 years,
with the effect persisting past time horizons of over 7 years. The implications of these findings
are discussed in this section.
Signaling Effect of Higher R&D Spending
As it should often be said, correlation does not imply causation. Higher expenditure does not
automatically lead to revenue growth, as the R&D productivity metric above illustrates. A budget
must still be utilized wisely in order to generate returns in the form of increased commercial
success. More likely, the correlation between R&D spending and revenue growth may be a
leading signaling effect demonstrating management confidence in the near-term pipeline. Each
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pharmaceutical firm relies on its own internal process for evaluating the probability of clinical
trial success and the potential commercial opportunity of a marketable product. The risk-reward
tradeoff must necessarily clear a prescribed hurdle for a drug candidate to proceed to the next
stage of development. Higher R&D spending may simply reflect an excess of such candidates in
the upcoming pipeline, motivating management to spend more in order to advance these drugs
to the next phase of clinical trials. In this signaling theory, increased R&D expenditure would
imply a perceived abundance of "shots on goal" in the near future and a determination to proceed
with costly late-stage clinical trials, the final steps towards FDA approval. For the attentive
investor, an increased guidance on R&D spending should then be accompanied by aggressive
schedules for Phase 3 trials and patient recruitment.
Influence of External R&D on Growth
The focus of the previous analysis on research and development costs booked in the income
statements neglects the potential of licensing, mergers, and acquisitions to boost revenue levels.
Rippy [70] documented the prevalence of licensing and M&A in the recent economic climate
and Getz et al. [71] determined that R&D spending generally remains flat after a merger or
acquisition then begins to increase after 4 years. These external paths to top-line growth would
not be reflected in the R&D productivity metrics developed above, hence the selection of
companies with a greater focus on organic growth for analysis. While licensing and M&A both
reduce the risk of trial failure by obtaining pipeline assets that are further along in the regulatory
approval process, this de-risking usually results in a price premium for the counterparty, to
acknowledge the higher value of the drug candidates being traded. A more systematic analysis of
R&D productivity may incorporate the cost of external R&D into the data set in order to adjust
for companies with a penchant for inorganic strategies.
Lack of Sensitivity to Product Margins
The focus on revenue growth as a performance metric does not mean to ignore the importance of
profitability on the financial outlook. While pharmaceutical and biotechnology products
routinely yield high gross margins, some variability in product margins may affect the viability of
this multivariate analysis. For instance, customized immunotherapy drugs such as the prostate
cancer vaccine Provenge, which requires the extraction of white blood cells from each patient
followed by propriety incubation and on-site re-infusion for treatment, would be expected to
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generate a lower profit margin regardless of its price tag. The presence of wide variation in other
relative costs may skew this analysis of R&D productivity.
9.6 Summary
This chapter provides some historical support for higher R&D spending. Multivariate analysis of
the revenue of mature pharmaceutical firms over the last 20 years has shown a strong correlation
between R&D spending and revenue growth, particularly over long time horizons of 7 years or
more. This correlation was found to be greater than any attributable to the R&D productivity of
particularly successful drug companies. The strong relationship between R&D spending and
future top-line growth may be due to internal hurdles to increasing research expenditure, causing
such decisions to be signals of confidence from management about the prospects of candidates in
the upcoming pipeline. Since past performance is not a guarantee of future results, only time will
tell when Merck CEO Ken Frazier or Pfizer CEO Ian Read made the right call.
109
110
10 Conclusion
Blending is a pivotal step in pharmaceutical manufacturing, ensuring consistent drug quality.
With recent advances in processing and analytical technology, an opportunity exists to transform
current batch practices to continuous manufacturing, thereby reducing the scale of operation and
improving quality control. This switch necessitates a rigorous understanding of the system, as the
timing of each process becomes crucial to factory operation. This thesis established an analytical
and experimental framework for characterizing and improving continuous pharmaceutical
blending. By investigating the relationship between process parameters and mixer performance,
this work reconciled previous continuous blending research with the pharmaceutical context and
developed general design principles for maximizing the variance reduction ratio.
A design of experiments was constructed to determine blending performance with respect to
physical design, operating parameters, and material properties. This methodology recognized the
urgency of process development during clinical trials and the cost of early stage API synthesis. A
multi-tier approach with less-intensive fill weight and residence time distribution experiments as
well as full blending runs allowed intermediate metrics to substitute as proxies for performance
while minimizing the use of API. Data analysis leveraged projections to latent structures in order
to account for multicollinearity within the system and discern the individual influence of various
parameters on the variance reduction ratio. The resulting correlations mapped the design space by
quantifying the first order effect of raw variables and intermediate metrics on performance.
Within the chosen design space, the most significant parameters included the choice of API, fill
fraction, the number of blade passes, the mean residence time, the Bodenstein number, and the
period of the input feed fluctuations. The divergence in blending performance between caffeine
and acetaminophen trials was attributed to weak radial mixing and deagglomeration during the
process. This finding suggests that one-dimensional axial models commonly employed in mixing
literature may not be a sufficient theoretical framework as continuous blending is applied to
cohesive pharmaceutical powders. The use of a paddle shaft with an increased shear rate was
shown to be effective in minimizing differences in blending performance with respect to API.
The overall framework yielded several insights into design principles for optimizing blending
performance. In physical design, increasing mean residence time and radial mixing provides an
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operational hedge against fluctuations in feed consistency and material properties, leading to
more robust processing. Multivariate analysis demonstrated the statistical efficiency of using
intermediate experimental metrics such as space time, mean residence time, and the number of
blade passes rather than the variance reduction ratio. These parameters should be maximized by
adjusting the mass flow rate and shaft rotation rate to determine the optimum fill fraction for the
given shaft design.
The methodology set forth in this thesis was demonstrated to be effective in distilling complex
system relationships into quantifiable first order effects. This framework thus validated several
findings from recent literature on powder dynamics and blending performance while establishing
broad design principles for future process optimization efforts. Multivariate analysis was shown
to be a cost-effective and high-leverage iterative strategy for discovering incremental boosts to
blending performance and serves as a practical tool for characterizing and understanding
pharmaceutical processes.
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